index,Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
0,prerank,NOD-like receptor signaling pathway,0.5683984735196068,3.2507106901059344,0.0,0.0,0.0,47/143,8.25%,GBP1;GBP5;GBP4;STAT1;OAS3;GBP2;STAT2;CASP5;IRF7;OAS1;IFI16;AIM2;GBP3;NOD2;OAS2;RBCK1;CCL2;RIPK2;CYBB;IRF9;CASP1;CASP4;CARD16;IL1B;P2RX7;MEFV;GSDMD;RNASEL;TANK;NFKBIA;CARD6;MAPK14;RNF31;MYD88;NAMPT;TLR4;IFNAR1;IFNAR2;TBK1;RIPK1;TNFAIP3;NOD1;ANTXR2;PRKCD;GABARAP;XIAP;NLRC4
1,prerank,Staphylococcus aureus infection,0.7011256629476271,3.1694475878047887,0.0,0.0,0.0,22/47,8.85%,FCGR1A;ICAM1;C2;C1QB;FCGR3B;FPR2;FCGR2A;FCGR2C;C1QC;HLA-DMB;C3AR1;FCGR3A;FPR1;SELPLG;PTAFR;HLA-DRA;HLA-DMA;HLA-DQB1;FCGR2B;KRT23;HLA-DPA1;C1QA
2,prerank,Influenza A,0.5874603182768193,3.1498625485705056,0.0,0.0,0.0,41/129,6.45%,RSAD2;CXCL10;STAT1;OAS3;STAT2;PML;ICAM1;MX1;IFIH1;TNFSF10;IRF7;OAS1;FAS;OAS2;CCL2;EIF2AK2;IRF9;ADAR;SOCS3;CASP1;JAK2;TRIM25;CALCOCO2;IL1B;MX2;CIITA;TNFRSF1A;TLR7;RNASEL;HLA-DMB;NFKBIA;BAK1;MYD88;TLR4;IFNAR1;IFNAR2;TBK1;HLA-DRA;HLA-DMA;BID;HLA-DQB1
3,prerank,Ribosome,-0.6699123835500279,-3.1473469544095094,0.0,0.0,0.0,82/148,11.65%,RPS27;RPS7;RPL9;RPS3A;RPS17;RPL39;RPS15A;RPL3;RPSA;RPL7;RPL13A;RPS18;RPLP0;RPL17;RPL13;RPS6;RPS21;RPL41;RPL11;RPL4;RPS3;RPL10;RPL26;RPS4X;RPS20;RPS23;RPL5;RPS5;RPL23;RPL30;RPS25;RPS14;RPL34;RPL18;RPS19;RPL37A;RPL10A;RPL18A;RPL27A;RPL27;RPS10;RPL22;RPL36;RPL6;RPS8;RPL32;RPL14;RPL23A;RPL35;RPS29;RPS28;RPL31;RPL12;RPS27A;RPLP2;RPL37;RPL35A;RPS10-NUDT3;RPL7A;RPS16;RPL38;RPL29;RPL24;RPS2;RPL21;RPLP1;RPL15;RPL19;RPL8;RPL36A;RPS13;RPS15;MRPS21;RPS26;MRPS2;RPS12;MRPL9;RPS24;MRPL34;RPS11;MRPS6;RSL24D1
4,prerank,Systemic lupus erythematosus,0.6033693103044866,3.012861177771811,0.0,0.0,0.0,35/75,10.97%,FCGR1A;H2BC18;TRIM21;C2;C1QB;H4C8;FCGR3B;CD40;FCGR2A;H2BC4;C1QC;HLA-DMB;FCGR3A;H3-3A;H2AC18;H2AC19;HLA-DRA;HLA-DMA;H3C4;HLA-DQB1;H3-3B;ACTN1;H2AC20;H3-5;H2AC7;HLA-DPA1;H2BC21;C1QA;TNF;H4C4;H2BC12;C1R;HLA-DRB1;SSB;H2BC5
5,prerank,Leishmaniasis,0.6195231791953157,2.852772986633788,0.0,0.0,0.0,28/62,9.07%,FCGR1A;STAT1;CYBB;JAK2;NCF1;IL1B;FCGR3B;FCGR2A;TLR2;FCGR2C;HLA-DMB;NFKBIA;FCGR3A;MAPK14;MYD88;TLR4;NCF2;PTPN6;HLA-DRA;HLA-DMA;HLA-DQB1;PTGS2;TGFB1;NCF4;HLA-DPA1;CR1L;IFNGR2;TNF
6,prerank,Hepatitis C,0.5204640321891189,2.8316391126414118,0.0,0.0,0.0,27/113,6.40%,RSAD2;CXCL10;STAT1;OAS3;STAT2;IFIT1;MX1;IRF7;OAS1;FAS;OAS2;EIF2AK2;IRF9;SOCS3;STAT3;MX2;TNFRSF1A;RNASEL;NFKBIA;CDKN1A;BAK1;IFNAR1;IFNAR2;TBK1;CFLAR;RIPK1;BID
7,prerank,Epstein-Barr virus infection,0.47219020172343057,2.7264156672172315,0.0,0.0,0.0,53/169,9.07%,CXCL10;STAT1;OAS3;ISG15;STAT2;TAP1;ICAM1;IRF7;TAP2;OAS1;FAS;GADD45B;OAS2;EIF2AK2;IRF9;STAT3;CIR1;LYN;CD40;TLR2;TAPBP;HLA-DMB;NFKBIA;GADD45G;CDKN1A;RELB;MAPK14;BAK1;MYD88;HLA-G;IFNAR1;HLA-C;HLA-E;IFNAR2;TBK1;B2M;HLA-DRA;HLA-DMA;RIPK1;BID;HLA-DQB1;PSMD3;TNFAIP3;HLA-B;NFKB2;HLA-F;ENTPD1;NFKBIE;RB1;HLA-A;HLA-DPA1;JAK3;TNF
8,prerank,Phagosome,0.5276561887103184,2.708175801085644,0.0,0.0,0.0,43/114,10.71%,FCGR1A;TAP1;TAP2;CYBB;VAMP3;NCF1;FCGR3B;FCGR2A;TLR2;FCGR2C;HLA-DMB;FCGR3A;ATP6V1B2;RILP;CTSS;MARCO;HLA-G;TLR4;HLA-C;HLA-E;ATP6V0D1;NCF2;HLA-DRA;HLA-DMA;CD36;HLA-DQB1;RAB5C;ATP6V1G1;CTSL;FCGR2B;TLR6;HLA-B;HLA-F;NCF4;CLEC7A;HLA-A;HLA-DPA1;RAB5A;C1R;STX12;LAMP2;HLA-DRB1;TUBA1A
9,prerank,Osteoclast differentiation,0.5051463901273084,2.6501799721127903,0.0,0.0,0.0,38/107,9.42%,FCGR1A;SOCS1;STAT1;STAT2;IRF9;LCP2;SOCS3;NCF1;IL1B;FCGR3B;TNFRSF1A;FCGR2A;LILRB3;FCGR2C;LILRB1;NFKBIA;CSF1;RELB;SIRPB1;FCGR3A;LILRA6;MAPK14;IFNAR1;IFNAR2;NCF2;JUNB;LILRB4;FCGR2B;NFKB2;TGFB1;TYROBP;CYLD;NCF4;SPI1;LILRB2;IFNGR2;TNF;GRB2
10,prerank,Complement and coagulation cascades,0.620908750273617,2.5258941019112786,0.0,0.0,0.0,9/33,4.07%,SERPING1;C4BPA;CD59;C2;C1QB;PLAUR;CD46;C1QC;C3AR1
11,prerank,Tuberculosis,0.4506320313957617,2.5062018108456785,0.0,0.0,0.0,47/136,10.68%,FCGR1A;STAT1;NOD2;RIPK2;JAK2;IL1B;IRAK2;FCGR3B;CIITA;TNFRSF1A;FCGR2A;TLR1;TLR2;FCGR2C;HLA-DMB;CLEC4E;IL10RB;FCGR3A;MAPK14;MYD88;CTSS;CASP10;TLR4;SRC;ATP6V0D1;HLA-DRA;HLA-DMA;FCER1G;BID;HLA-DQB1;RAB5C;FCGR2B;TLR6;TGFB1;CEBPB;VDR;CLEC7A;HLA-DPA1;CR1L;IFNGR2;TNF;RAB5A;SPHK1;RFX5;CD74;LAMP2;HLA-DRB1
12,prerank,Pertussis,0.5471547494940828,2.4459046169186363,0.0,0.0,0.0,20/55,9.89%,SERPING1;IRF1;C4BPA;C2;C1QB;CASP1;IL1B;CASP7;C1QC;MAPK14;MYD88;TLR4;LY96;TICAM2;NOD1;C1QA;TNF;PYCARD;C1R;TICAM1
13,prerank,Measles,0.45931318741604793,2.3852920876943764,0.0,0.0,0.0,30/109,6.93%,STAT1;OAS3;STAT2;MX1;IFIH1;IRF7;OAS1;FAS;OAS2;EIF2AK2;IRF9;ADAR;STAT3;IL1B;MX2;CD46;TLR7;TLR2;NFKBIA;STAT5A;BAK1;MYD88;TLR4;IFNAR1;IFNAR2;TBK1;BID;HSPA6;TNFAIP3;FCGR2B
14,prerank,Necroptosis,0.44335701142889933,2.3681416485027613,0.0,0.0,0.0,42/119,9.89%,STAT1;STAT2;TNFSF10;FAS;ZBP1;MLKL;RBCK1;EIF2AK2;CYBB;IRF9;CASP1;JAK2;STAT3;IL1B;CHMP5;TNFRSF1A;STAT5A;H2AC18;H2AC19;RNF31;TLR4;IFNAR1;IFNAR2;CFLAR;TICAM2;PLA2G4A;GLUL;RIPK1;BID;CHMP2B;TNFAIP3;CYLD;H2AC20;XIAP;H2AC7;IFNGR2;JAK3;TNF;CHMP2A;SPATA2L;PYCARD;TICAM1
15,prerank,African trypanosomiasis,0.6717804722788077,2.3419528075350895,0.0,0.00011711630964118191,0.001,7/21,4.93%,IDO1;APOL1;ICAM1;FAS;IL1B;F2RL1;MYD88
16,prerank,Proteasome,0.5426515061234789,2.297825502179795,0.0,0.00021959308057721612,0.002,14/42,10.07%,PSME2;PSMB9;PSMB8;PSMB10;PSMB3;PSME1;PSMA4;POMP;PSMD3;PSMA2;PSMB4;PSMA5;PSMA3;PSMB2
17,prerank,Toxoplasmosis,0.4562114118050391,2.260172241952749,0.0,0.0005166896013581555,0.005,30/84,10.68%,SOCS1;STAT1;JAK2;STAT3;CIITA;TNFRSF1A;CD40;TLR2;HLA-DMB;NFKBIA;IL10RB;MAPK14;MYD88;TLR4;LY96;HLA-DRA;HLA-DMA;HLA-DQB1;HSPA6;TGFB1;XIAP;HLA-DPA1;BCL2L1;IFNGR2;TNF;PPIF;ALOX5;HSPA8;CHUK;HLA-DRB1
18,prerank,Neutrophil extracellular trap formation,0.40550810454968567,2.2496945027436697,0.0,0.0004879846235049246,0.005,38/131,9.90%,FCGR1A;H2BC18;CYBB;CASP1;CASP4;NCF1;TLR8;H4C8;FCGR3B;HDAC4;FPR2;GSDMD;TLR7;FCGR2A;H2BC4;TLR2;FCGR3A;H3-3A;MAPK14;H2AC18;H2AC19;FPR1;TLR4;SRC;NCF2;SELPLG;H3C4;H3-3B;H2AC20;NCF4;H3-5;CLEC7A;H2AC7;CR1L;H2BC21;H4C4;H2BC12;PPIF
19,prerank,TNF signaling pathway,0.43821685783210085,2.217704932765165,0.0,0.0005547614667213881,0.006,24/89,7.70%,CXCL10;IRF1;ICAM1;FAS;NOD2;MLKL;CCL2;SOCS3;BCL3;IL1B;CASP7;TNFRSF1A;NFKBIA;CSF1;IL15;MAPK14;CASP10;JUNB;CFLAR;RIPK1;TNFAIP3;CREB5;PTGS2;CEBPB
20,prerank,Coronavirus disease,-0.46332760982541293,-2.2083479855041865,0.0,0.00040627844504140487,0.001,75/170,6.94%,RPS27;RPS7;RPL9;RPS3A;RPS17;RPL39;RPS15A;RPL3;RPSA;RPL7;RPL13A;RPS18;RPLP0;RPL17;RPL13;RPS6;RPS21;RPL41;RPL11;RPL4;RPS3;RPL10;RPL26;RPS4X;RPS20;RPS23;RPL5;RPS5;RPL23;RPL30;RPS25;RPS14;RPL34;RPL18;RPS19;RPL37A;RPL10A;RPL18A;RPL27A;RPL27;RPS10;RPL22;RPL36;RPL6;RPS8;RPL32;RPL14;RPL23A;RPL35;RPS29;RPS28;RPL31;RPL12;RPS27A;PLCG1;RPLP2;RPL37;RPL35A;RPS10-NUDT3;RPL7A;RPS16;RPL38;RPL29;RPL24;RPS2;RPL21;RPLP1;JUN;RPL15;RPL19;RPL8;RPL36A;RPS13;RPS15;CXCL8
21,prerank,RIG-I-like receptor signaling pathway,0.4836773387463602,2.155842730776982,0.0,0.0013175584834632967,0.014,13/48,7.47%,CXCL10;ISG15;IFIH1;IRF7;DHX58;TRIM25;TANK;NFKBIA;MAPK14;CASP10;TBK1;RIPK1;CYLD
22,prerank,Antigen processing and presentation,0.45202585895687514,2.126330471510975,0.0,0.0015057811239580533,0.016,29/66,10.68%,TAP1;PSME2;TAP2;IFI30;PSME1;CIITA;TAPBP;HLA-DMB;CTSS;HLA-G;HLA-C;HLA-E;B2M;HLA-DRA;HLA-DMA;HLA-DQB1;HSPA6;CTSL;HLA-B;HLA-F;HLA-A;HLA-DPA1;TNF;PDIA3;RFX5;HSPA8;CD74;CTSB;HLA-DRB1
23,prerank,JAK-STAT signaling pathway,0.4098872748953864,2.0950270601286887,0.0,0.002156004791121758,0.025,26/84,9.42%,SOCS1;STAT1;STAT2;IRF9;CSF2RB;SOCS3;JAK2;STAT3;IL15RA;IL13RA1;CDKN1A;IL10RB;STAT5A;IL15;IFNAR1;IFNAR2;PIM1;PTPN6;CISH;CSF3R;IL12RB1;MCL1;BCL2L1;IFNGR2;JAK3;GRB2
24,prerank,Prolactin signaling pathway,0.4896999083792944,2.0896175415525478,0.0,0.0021386456543172347,0.026,10/46,6.00%,SOCS1;STAT1;IRF1;SOCS3;JAK2;STAT3;STAT5A;MAPK14;SRC;CISH
25,prerank,Toll-like receptor signaling pathway,0.42189087694262656,2.0221235819723375,0.0,0.004172268530967106,0.049,21/77,7.06%,CXCL10;STAT1;IRF7;IL1B;TLR8;TLR7;CD40;TLR1;TLR2;NFKBIA;TLR5;MAPK14;MYD88;TLR4;IFNAR1;IFNAR2;LY96;TBK1;TICAM2;RIPK1;TLR6
26,prerank,Fc gamma R-mediated phagocytosis,0.4102459662062645,2.014946918811428,0.0,0.004497266290221386,0.053,25/75,10.04%,FCGR1A;LIMK2;NCF1;LIMK1;FCGR3B;LYN;FCGR2A;FCGR3A;PAK1;PTPRC;VASP;HCK;MARCKS;PLA2G4A;WAS;GSN;FCGR2B;PRKCD;ACTR3;ARPC5;ARPC3;ACTR2;SPHK1;ASAP1;PIP5K1A
27,prerank,Kaposi sarcoma-associated herpesvirus infection,0.36933259799647356,2.011627372166703,0.0,0.004391861611544322,0.054,40/153,8.74%,STAT1;STAT2;ICAM1;IRF7;FAS;EIF2AK2;IRF9;ATG3;JAK2;CCR1;MICB;GNB4;STAT3;GNG10;LYN;TNFRSF1A;ZFP36;NFKBIA;CDKN1A;MAPK14;BAK1;TCF7L2;HLA-G;IFNAR1;SRC;HLA-C;HLA-E;IFNAR2;TBK1;HCK;BID;PTGS2;HLA-B;HLA-F;HIF1A;MICA;GABARAP;RB1;HLA-A;CLEC2B
28,prerank,Type I diabetes mellitus,0.5029331013427589,1.9593518465610729,0.0,0.006376332413797683,0.078,14/28,9.07%,FAS;IL1B;HLA-DMB;HLA-G;HLA-C;HLA-E;HLA-DRA;HLA-DMA;HLA-DQB1;HLA-B;HLA-F;HLA-A;HLA-DPA1;TNF
29,prerank,Cytosolic DNA-sensing pathway,0.4479128684506319,1.9306131558621098,0.004273504273504274,0.007403423859460428,0.094,11/44,6.31%,CXCL10;IRF7;AIM2;ZBP1;ADAR;CASP1;IL1B;CGAS;NFKBIA;TBK1;RIPK1
30,prerank,Viral myocarditis,0.43638029067550566,1.884765971330477,0.0045871559633027525,0.009813539049243866,0.128,15/43,8.51%,ICAM1;EIF4G3;CD40;HLA-DMB;HLA-G;HLA-C;HLA-E;HLA-DRA;HLA-DMA;BID;HLA-DQB1;HLA-B;HLA-F;HLA-A;HLA-DPA1
31,prerank,C-type lectin receptor signaling pathway,0.37874429564398926,1.8840430538591841,0.0,0.009486421080935736,0.128,20/81,8.13%,STAT1;STAT2;IRF1;IRF9;CASP1;BCL3;IL1B;NFKBIA;CLEC4E;RELB;PAK1;MAPK14;CLEC4D;SRC;FCER1G;PTGS2;NFKB2;CYLD;PRKCD;CLEC7A
32,prerank,Allograft rejection,0.48728844813684147,1.8815555261081895,0.00411522633744856,0.009463753408101959,0.131,14/27,9.07%,FAS;CD40;HLA-DMB;HLA-G;HLA-C;HLA-E;HLA-DRA;HLA-DMA;HLA-DQB1;HLA-B;HLA-F;HLA-A;HLA-DPA1;TNF
33,prerank,Inflammatory bowel disease,0.4263016790185104,1.8437255809696464,0.008658008658008658,0.012571703863045623,0.175,16/45,9.07%,STAT1;NOD2;STAT3;IL1B;TLR2;HLA-DMB;TLR5;TLR4;HLA-DRA;HLA-DMA;HLA-DQB1;IL12RB1;TGFB1;HLA-DPA1;IFNGR2;TNF
34,prerank,Lipid and atherosclerosis,0.3175471422620139,1.821858673086116,0.0,0.014852477449949891,0.203,33/162,7.06%,ICAM1;TNFSF10;IRF7;FAS;SOD2;CCL2;CYBB;CASP1;JAK2;NCF1;STAT3;IL1B;CASP7;LYN;TNFRSF1A;CD40;TLR2;TANK;NFKBIA;NFE2L2;MAPK14;MYD88;ATF6;TLR4;SRC;LY96;NCF2;TBK1;TICAM2;CD36;BID;HSPA6;TLR6
35,prerank,Rheumatoid arthritis,0.3902412300049489,1.8181904340903636,0.0,0.014570646758299987,0.205,19/61,9.07%,ICAM1;TNFSF13B;CCL2;IL1B;TLR2;HLA-DMB;CSF1;ATP6V1B2;IL15;TLR4;ATP6V0D1;HLA-DRA;HLA-DMA;HLA-DQB1;ATP6V1G1;CTSL;TGFB1;HLA-DPA1;TNF
36,prerank,T cell receptor signaling pathway,-0.4135758041810333,-1.81116654690835,0.0,0.041440401394223295,0.124,28/89,14.92%,CD247;LCK;CD3E;CD3D;CD8A;ZAP70;LAT;CD3G;NFATC3;CD40LG;PRKCQ;CD28;CARD11;PLCG1;CD8B;ITK;CD4;JUN;CBLB;NFATC2;FYN;GRAP2;CDK4;RASGRP1;HRAS;PIK3R1;PPP3CC;PDCD1
37,prerank,Autoimmune thyroid disease,0.46368165906145037,1.78816037074483,0.012195121951219513,0.01781840996683696,0.251,13/27,8.51%,FAS;CD40;HLA-DMB;HLA-G;HLA-C;HLA-E;HLA-DRA;HLA-DMA;HLA-DQB1;HLA-B;HLA-F;HLA-A;HLA-DPA1
38,prerank,Calcium signaling pathway,-0.40432531590930465,-1.7485974342476192,0.002364066193853428,0.07414581622005639,0.263,37/90,25.20%,PLCD1;ATP2B4;VEGFB;PLCB2;PLCG1;ITPKB;ATP2A3;PRKACB;ITPR3;TPCN1;SLC25A6;ORAI1;PDGFB;P2RX5;ADORA2A;CAMK2G;PHKG1;ADRB2;CACNA1I;LTB4R2;CAMK1;F2R;CALM1;ERBB2;P2RX1;PPP3CC;HRH2;PHKG2;CAMK4;ADCY9;ATP2B1;PRKCA;FGFR1;STIM1;VDAC3;PDGFD;PLCB3
39,prerank,Salivary secretion,-0.4803094630425678,-1.7478428023525192,0.00390625,0.05964167573207824,0.265,18/37,25.20%,ATP2B4;KCNN4;PLCB2;PRKACB;ITPR3;ADRB2;ATP1A3;CAMP;CALM1;VAMP2;ATP1A1;SLC9A1;ADCY9;ATP2B1;AMY2B;PRKCA;FXYD2;PLCB3
40,prerank,Cell adhesion molecules,0.3615301139045302,1.74214682646539,0.01098901098901099,0.024301634250545247,0.325,23/78,8.51%,CD274;ICAM1;PDCD1LG2;NECTIN2;SDC3;SELL;SIGLEC1;CD40;HLA-DMB;HLA-G;HLA-C;HLA-E;NTNG2;PTPRC;SELPLG;HLA-DRA;HLA-DMA;HLA-DQB1;MPZL1;HLA-B;HLA-F;HLA-A;HLA-DPA1
41,prerank,Th1 and Th2 cell differentiation,-0.40168531058740725,-1.6706728248289788,0.0037174721189591076,0.12486290877605843,0.527,17/72,6.04%,CD247;TBX21;LCK;CD3E;CD3D;ZAP70;LAT;CD3G;NFATC3;STAT4;PRKCQ;IL2RB;PLCG1;GATA3;CD4;JUN;NFATC2
42,prerank,Human immunodeficiency virus 1 infection,0.2892717134866463,1.6608139881570014,0.0,0.04040512682620776,0.472,34/168,7.45%,TAP1;TAP2;FAS;LIMK2;TRIM5;BST2;GNB4;GNG10;SAMHD1;LIMK1;APOBEC3A;APOBEC3B;CGAS;TNFRSF1A;TLR2;TAPBP;NFKBIA;PAK1;MAPK14;BAK1;MYD88;HLA-G;TLR4;APOBEC3G;HLA-C;HLA-E;CUL1;TBK1;B2M;RIPK1;BID;PTK2B;HLA-B;HLA-F
43,prerank,Transcriptional misregulation in cancer,0.3061850700880759,1.653115890271452,0.0,0.04132972927074341,0.49,22/123,9.03%,FCGR1A;ETV7;PML;AFF1;GADD45B;BCL6;ETV6;DUSP6;CD40;GADD45G;CDKN1A;H3-3A;LMO2;BAK1;H3C4;H3-3B;CEBPB;H3-5;SPI1;MAX;BCL2L1;TFE3
44,prerank,Viral carcinogenesis,0.2849258462816769,1.6364886262764151,0.0,0.044143839787830104,0.513,35/158,9.55%,H2BC18;IRF7;EIF2AK2;POLB;IRF9;STAT3;H4C8;LYN;SP100;HDAC4;H2BC4;LTBR;NFKBIA;CDKN1A;STAT5A;BAK1;HLA-G;SRC;HLA-C;HLA-E;ATP6V0D1;GSN;CREB5;ACTN1;HLA-B;NFKB2;HLA-F;GTF2B;RB1;HLA-A;H2BC21;JAK3;H4C4;GRB2;H2BC12
45,prerank,Graft-versus-host disease,0.4093255275391676,1.6304673115360049,0.022123893805309734,0.04492874428609841,0.524,14/31,9.07%,FAS;IL1B;HLA-DMB;HLA-G;HLA-C;HLA-E;HLA-DRA;HLA-DMA;HLA-DQB1;HLA-B;HLA-F;HLA-A;HLA-DPA1;TNF
46,prerank,Aldosterone synthesis and secretion,-0.40998230308230255,-1.607841792364554,0.012610340479192938,0.20615729096958144,0.753,21/51,25.87%,ATP2B4;PLCB2;PRKACB;ITPR3;ORAI1;CAMK2G;CACNA1I;SCARB1;ATP1A3;CAMK1;CALM1;ATF4;ATP1A1;CREB3L4;CAMK4;DAGLB;ADCY9;ATP2B1;PRKCA;PLCB3;LIPE
47,prerank,Tryptophan metabolism,0.4312969552841265,1.605979455367714,0.06521739130434782,0.05094559469391413,0.577,4/25,6.39%,IDO1;AANAT;IL4I1;AOC1
48,prerank,Intestinal immune network for IgA production,0.3952643235995575,1.6043830428639343,0.03765690376569038,0.05027635863882167,0.579,11/33,8.51%,TNFSF13B;IL15RA;CD40;LTBR;HLA-DMB;IL15;HLA-DRA;HLA-DMA;HLA-DQB1;TGFB1;HLA-DPA1
49,prerank,SNARE interactions in vesicular transport,0.40584464800591535,1.603824587775959,0.03361344537815126,0.049188850049296406,0.58,4/31,3.45%,VAMP5;STX11;VAMP3;STX3
50,prerank,DNA replication,-0.4612428548986661,-1.603520435346973,0.01694915254237288,0.1886147681104722,0.769,23/30,46.87%,MCM7;MCM5;LIG1;POLD2;MCM6;MCM3;RPA1;POLE3;POLD1;RFC4;MCM4;POLE;PRIM1;MCM2;RFC2;FEN1;PCNA;RNASEH2A;RNASEH2C;POLD4;RPA3;RNASEH1;RFC1
51,prerank,Wnt signaling pathway,-0.37437827634440096,-1.6030838103027494,0.00851581508515815,0.16810899214824354,0.77,41/88,35.32%,TCF7;NFATC3;PLCB2;LEF1;TLE2;SERPINF1;PRKACB;JUN;NFATC2;CSNK1E;TPTEP2-CSNK1E;CBY1;WNT10B;PORCN;CCND2;CAMK2G;CTNNBIP1;AXIN2;LGR6;MYC;DVL1;PRICKLE3;PPP3CC;RUVBL1;RYK;AXIN1;CSNK2A2;SMAD3;PRKCA;TLE1;PPARD;PLCB3;TLE3;WNT10A;RNF43;CACYBP;RBX1;MAPK9;DVL2;BTRC;NFATC1
52,prerank,Hepatitis B,0.3019401210835842,1.5915082922140547,0.013793103448275862,0.051624336942970986,0.601,23/126,7.44%,STAT1;STAT2;IFIH1;IRF7;FAS;JAK2;STAT3;TLR2;NFKBIA;CDKN1A;STAT5A;MAPK14;MYD88;CASP10;TLR4;IFNAR1;SRC;TBK1;TICAM2;BID;PTK2B;CREB5;TGFB1
53,prerank,Chemokine signaling pathway,0.2879623344224727,1.5894306843256396,0.0,0.050984633463794525,0.605,22/131,7.69%,CXCL10;STAT1;STAT2;CXCL16;CCL2;JAK2;CCR1;GNB4;NCF1;STAT3;GNG10;LYN;NFKBIA;ARRB2;PAK1;SRC;HCK;WAS;PTK2B;CCR2;PRKCD;FGR
54,prerank,Primary immunodeficiency,-0.4487852065420537,-1.582858613098542,0.01576872536136662,0.1866443176520214,0.831,16/33,16.24%,IL7R;LCK;CD3E;CD3D;CD8A;ZAP70;CD40LG;UNG;CD8B;ADA;CD4;CD79A;ORAI1;TNFRSF13B;TNFRSF13C;CD19
55,prerank,Bile secretion,-0.4507554960705769,-1.5781854986060315,0.01937984496124031,0.17750674607899924,0.838,13/29,24.63%,EPHX1;PRKACB;SCARB1;ATP1A3;ABCB1;SLC2A1;ATP1A1;SLC9A1;SLC9A3;ADCY9;HMGCR;ABCC3;FXYD2
56,prerank,Herpes simplex virus 1 infection,0.2485365144347351,1.5647138651305132,0.0,0.058125333676264844,0.65,43/330,6.45%,STAT1;OAS3;STAT2;PML;TAP1;IFIH1;IRF7;TAP2;OAS1;FAS;OAS2;CCL2;EIF2AK2;IRF9;BST2;NECTIN2;SOCS3;JAK2;ZNF200;ZNF267;IL1B;SP100;CGAS;TNFRSF1A;TLR2;RNASEL;TAPBP;HLA-DMB;NFKBIA;BAK1;MYD88;HLA-G;IFNAR1;SRC;HLA-C;HLA-E;IFNAR2;TBK1;B2M;HLA-DRA;HLA-DMA;BID;HLA-DQB1
57,prerank,Human cytomegalovirus infection,0.26773956928091974,1.5537043304168996,0.0,0.06021522601019492,0.669,32/171,7.45%,TAP1;TAP2;FAS;CCL2;CCR1;GNB4;STAT3;GNG10;IL1B;CGAS;TNFRSF1A;TAPBP;NFKBIA;CDKN1A;IL10RB;MAPK14;BAK1;AKAP13;HLA-G;SRC;HLA-C;HLA-E;TBK1;B2M;RIPK1;BID;PTK2B;CREB5;PTGS2;HLA-B;GNA13;HLA-F
58,prerank,Legionellosis,0.3538880214893619,1.5479958177867292,0.03255813953488372,0.06082728331988886,0.678,16/49,10.13%,CASP1;IL1B;CASP7;TLR2;NFKBIA;TLR5;MYD88;TLR4;HSPA6;NFKB2;RAB1A;NLRC4;CR1L;TNF;PYCARD;HSPA8
59,prerank,Acute myeloid leukemia,0.34325177560095194,1.5453610488300158,0.04950495049504951,0.06048220847898181,0.684,8/59,5.80%,FCGR1A;PML;STAT3;PIM2;DUSP6;STAT5A;TCF7L2;PIM1
60,prerank,Metabolism of xenobiotics by cytochrome P450,-0.5021448375919009,-1.5422201324124536,0.028534370946822308,0.22947960837422016,0.922,11/19,21.61%,EPHX1;GSTM2;AKR7A2;CYP2S1;ADH5;GSTM1;GSTM4;CYP2D6;GSTP1;MGST3;CBR3
61,prerank,Insulin secretion,-0.42556402292019935,-1.5368588817028017,0.029023746701846966,0.22257808350652966,0.924,15/35,25.20%,KCNN4;PLCB2;PRKACB;ITPR3;CAMK2G;ATP1A3;SLC2A1;VAMP2;ATF4;ATP1A1;CREB3L4;ADCY9;PRKCA;FXYD2;PLCB3
62,prerank,NF-kappa B signaling pathway,0.3080219390012823,1.5309494889380106,0.023529411764705882,0.06447252845747065,0.715,25/86,9.07%,ICAM1;TNFSF13B;GADD45B;TRIM25;IL1B;LYN;TNFRSF1A;CD40;LTBR;NFKBIA;GADD45G;RELB;MYD88;TLR4;LY96;CFLAR;TICAM2;RIPK1;TNFAIP3;PTGS2;NFKB2;CYLD;XIAP;BCL2L1;TNF
63,prerank,Arachidonic acid metabolism,-0.4408035446797053,-1.5284034973782754,0.026143790849673203,0.2232790254391835,0.94,14/30,24.44%,PTGDS;GPX3;PRXL2B;PLA2G4B;GPX7;JMJD7-PLA2G4B;EPHX2;GGT1;PLB1;PTGES2;PLA2G6;AKR1C3;CBR3;LTC4S
64,prerank,Arrhythmogenic right ventricular cardiomyopathy,-0.4312588004204029,-1.507808553108572,0.028871391076115485,0.25200097684434875,0.969,17/30,35.40%,TCF7;LEF1;LMNA;ATP2A3;CACNA2D2;ITGB1;ITGB7;EMD;CACNB1;ITGA6;ITGA5;CACNA2D3;CACNA2D4;JUP;ITGA3;DAG1;ACTG1
65,prerank,Asthma,0.44598238840755494,1.4992431159891746,0.07723577235772358,0.07616004724019212,0.779,11/18,13.71%,CD40;HLA-DMB;HLA-DRA;HLA-DMA;FCER1G;HLA-DQB1;HLA-DPA1;TNF;HLA-DRB1;HLA-DRB5;RNASE3
66,prerank,Cytokine-cytokine receptor interaction,0.27890503382588333,1.4892390534990256,0.027972027972027972,0.07918864321122993,0.791,30/122,9.07%,CXCL10;TNFSF10;FAS;TNFSF13B;CXCL16;CCL2;CSF2RB;IL27;CCR1;IL15RA;IL1B;IL13RA1;IL1RN;TNFRSF1A;CD40;LTBR;IL10RB;CSF1;IL15;IFNAR1;IFNAR2;CSF3R;CCR2;IL12RB1;TGFB1;IL1RAP;IL17RC;IL17RA;IFNGR2;TNF
67,prerank,Base excision repair,-0.4164166847904494,-1.482168069587963,0.05179282868525897,0.29658326488022557,0.987,18/31,31.30%,UNG;NTHL1;LIG1;POLD2;PARP1;APEX1;PARP2;HMGB1;NEIL2;POLE3;POLD1;NEIL1;MPG;XRCC1;POLE;OGG1;FEN1;MUTYH
68,prerank,Fatty acid elongation,-0.4625163523087277,-1.470036354979896,0.05771812080536913,0.3103967320116333,0.991,13/20,36.67%,TECR;THEM4;HADH;THEM5;PPT2;ACOT2;HACD3;ACAA2;HACD2;MECR;HSD17B12;HADHA;ACOT1
69,prerank,Human papillomavirus infection,0.24514750699322457,1.4556162738595866,0.008130081300813009,0.09413499605121414,0.845,37/200,9.97%,STAT1;ISG15;STAT2;IRF1;OASL;MX1;FAS;EIF2AK2;IRF9;MX2;TNFRSF1A;CDKN1A;ATP6V1B2;BAK1;TCF7L2;HLA-G;IFNAR1;HLA-C;HLA-E;ATP6V0D1;IFNAR2;TBK1;ATP6V1G1;CREB5;PTGS2;HLA-B;HLA-F;RB1;PPP2R2A;HLA-A;HES4;TNF;PPP2R5B;GRB2;TICAM1;FZD2;PTGER4
70,prerank,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.3018518816172347,1.4555018886898217,0.025974025974025976,0.09242428769183274,0.845,15/82,8.06%,BATF2;CD274;STAT1;JAK2;STAT3;TLR2;NFKBIA;MAPK14;MYD88;TLR4;PTPN6;TICAM2;BATF;HIF1A;NFKBIE
71,prerank,IL-17 signaling pathway,0.3112140624716374,1.440142680463161,0.0514018691588785,0.09885681227439765,0.869,14/57,9.07%,CXCL10;CCL2;IL1B;NFKBIA;MAPK14;USP25;TBK1;TNFAIP3;PTGS2;CEBPB;S100A9;IL17RC;IL17RA;TNF
72,prerank,Cholesterol metabolism,0.3795424231251826,1.4294476639411795,0.06692913385826772,0.10286367303038452,0.883,5/26,6.30%,SORT1;CETP;NPC2;PLTP;CD36
73,prerank,Pathogenic Escherichia coli infection,0.2513818858667658,1.4260641299146113,0.030534351145038167,0.10263087134345679,0.887,28/142,9.07%,TNFSF10;FAS;CASP1;CASP4;IL1B;SEC24D;CASP7;TNFRSF1A;FCGR2A;NFKBIA;TLR5;PAK1;MAPK14;BAK1;MYD88;TLR4;SRC;PTPN6;WIPF1;RIPK1;CYTH4;GNA13;RAB1A;ACTR3;ARPC5;ARPC3;ACTR2;TNF
74,prerank,Protein digestion and absorption,-0.40269613973096385,-1.4027189761554801,0.08068783068783068,0.510737147466495,1.0,11/29,19.67%,COL6A2;KCNN4;COL9A3;DPP4;COL5A3;PRSS1;ATP1A3;MME;SLC3A2;ATP1A1;SLC9A3
75,prerank,Cardiac muscle contraction,-0.3684864326058348,-1.4006106481317389,0.06322580645161291,0.4915113861958807,1.0,21/46,31.81%,TPM2;ATP2A3;CACNA2D2;ATP1A3;COX7C;CACNB1;COX3;ATP1A1;SLC9A1;COX2;UQCRH;CYTB;COX1;FXYD2;COX4I1;SLC9A6;COX7A2L;CACNA2D3;COX6C;CACNA2D4;UQCRHL
76,prerank,AGE-RAGE signaling pathway in diabetic complications,0.29213244995541154,1.3906813631401382,0.0594059405940594,0.12160913358862381,0.927,12/63,7.64%,STAT1;ICAM1;CCL2;CYBB;JAK2;STAT3;IL1B;STAT5A;MAPK14;PIM1;TGFB1;PRKCD
77,prerank,Dilated cardiomyopathy,-0.3781635984574446,-1.3865878933294005,0.07932379713914174,0.5217427791221722,1.0,17/36,35.40%,TPM2;LMNA;ATP2A3;PRKACB;CACNA2D2;ITGB1;ITGB7;EMD;CACNB1;ITGA6;ADCY9;ITGA5;CACNA2D3;CACNA2D4;ITGA3;DAG1;ACTG1
78,prerank,Th17 cell differentiation,-0.31731222498447387,-1.379824159025554,0.047961630695443645,0.521854989359374,1.0,19/91,8.80%,CD247;TBX21;LCK;CD3E;CD3D;ZAP70;LAT;CD3G;NFATC3;RORC;PRKCQ;IL2RB;PLCG1;GATA3;CD4;JUN;NFATC2;IL27RA;IL21R
79,prerank,Phosphatidylinositol signaling system,-0.3291856887510405,-1.3791354049330595,0.06012269938650307,0.5006458475032949,1.0,24/75,26.99%,PLCD1;DGKZ;DGKA;PLCB2;PLCG1;ITPKB;DGKD;ITPR3;INPP5E;CALM1;PIK3R1;DGKQ;PI4K2A;INPP5B;PIP4K2B;PIK3C2B;IMPA2;DGKG;PRKCA;PI4KA;PLCB3;DGKE;INPP4B;PIK3R2
80,prerank,Choline metabolism in cancer,-0.3290985973951361,-1.3654709026829566,0.0684931506849315,0.5319774630811718,1.0,28/68,33.91%,DGKZ;DGKA;RALGDS;PLCG1;DGKD;JUN;PLA2G4B;JMJD7-PLA2G4B;PDGFB;HRAS;PIK3R1;DGKQ;DGKG;PRKCA;RPS6KB2;GPCPD1;TSC2;AKT3;TSC1;EIF4EBP1;PDGFD;DGKE;PIK3R2;MAPK3;MTOR;MAPK9;PLD2;PIP5K1C
81,prerank,Glyoxylate and dicarboxylate metabolism,-0.4184757360278233,-1.345593786657668,0.10317460317460317,0.5893745976067313,1.0,13/23,33.41%,AMT;SHMT2;SHMT1;PGP;HYI;AFMID;MCEE;ACSS1;PCCB;GLYCTK;GRHPR;MDH2;MDH1
82,prerank,Mineral absorption,-0.38367034525824745,-1.3449315215763475,0.09448818897637795,0.5691798503652066,1.0,13/30,24.63%,HMOX2;ATP2B4;SLC26A6;ATP1A3;CYBRD1;MT1X;ATP1A1;HMOX1;SLC9A3;ATP2B1;MT1F;SLC46A1;FXYD2
83,prerank,Nucleotide excision repair,-0.3600282725759469,-1.3410197368853995,0.10506329113924051,0.5616330719876221,1.0,22/40,37.56%,LIG1;POLD2;GTF2H4;RPA1;ERCC5;BIVM-ERCC5;POLE3;ERCC3;POLD1;RFC4;DDB1;ERCC2;POLE;ERCC1;XPC;DDB2;RFC2;XPA;RBX1;GTF2H3;PCNA;CUL4A
84,prerank,Malaria,0.33063769995084047,1.329818910330735,0.10948905109489052,0.1660272565828552,0.972,11/32,9.07%,ICAM1;CCL2;IL1B;CD40;TLR2;MYD88;TLR4;CD36;TGFB1;CR1L;TNF
85,prerank,Phospholipase D signaling pathway,-0.30442994046406424,-1.321924159132505,0.07475490196078431,0.6161287855801987,1.0,31/91,26.99%,FCER1A;DGKZ;DGKA;PLCB2;RALGDS;PLCG1;DGKD;FYN;PLA2G4B;JMJD7-PLA2G4B;CXCL8;LPAR5;PDGFB;CYTH3;F2R;HRAS;RRAS2;PIK3R1;DGKQ;AGPAT4;ADCY9;DGKG;PRKCA;TSC2;AKT3;TSC1;PDGFD;PLCB3;DGKE;RALA;PIK3R2
86,prerank,Chagas disease,0.2707204915166206,1.3201924564117287,0.07692307692307693,0.17066774222461237,0.978,18/75,9.07%,FAS;CCL2;C1QB;IL1B;TNFRSF1A;TLR2;C1QC;NFKBIA;MAPK14;MYD88;TLR4;CFLAR;TLR6;TGFB1;PPP2R2A;C1QA;IFNGR2;TNF
87,prerank,"Growth hormone synthesis, secretion and action",0.26314018248172333,1.312504220712448,0.08602150537634409,0.17509848261107852,0.981,9/78,7.00%,SOCS1;STAT1;SOCS3;JAK2;STAT3;STAT5A;MAPK14;JUNB;CREB5
88,prerank,Various types of N-glycan biosynthesis,-0.37977149361912316,-1.3120765908646044,0.11952191235059761,0.6351583090443734,1.0,23/31,48.21%,MGAT4A;MAN1B1;B4GALT3;MAN1C1;MGAT4B;HEXA;ALG1;STT3A;HEXB;RPN2;ALG12;ALG3;STT3B;DDOST;B4GALNT3;ALG9;RPN1;ALG2;ALG13;FUT8;ST3GAL3;MAN2A2;MAN1A2
89,prerank,Neuroactive ligand-receptor interaction,-0.31887595131667784,-1.3114863874391156,0.0828258221680877,0.6154698154330689,1.0,20/69,14.69%,GZMA;S1PR5;S1PR1;THRA;S1PR4;VIPR1;NMUR1;PRSS1;P2RY8;P2RX5;ADORA2A;P2RY10;ADRB2;P2RY11;LTB4R2;F2R;PTGER2;P2RX1;PTGDR;HRH2
90,prerank,Mannose type O-glycan biosynthesis,-0.44286107055151314,-1.3045262266508317,0.13279132791327913,0.6228519414781432,1.0,6/16,17.62%,POMT1;B4GAT1;LARGE2;POMGNT1;B4GALT3;POMGNT2
91,prerank,Amino sugar and nucleotide sugar metabolism,-0.3485910381067178,-1.3032812375026332,0.121251629726206,0.6080284573951915,1.0,32/42,54.64%,AMDHD2;MPI;CYB5R1;UXS1;PGM1;PMM1;GPI;UAP1;PMM2;HEXA;GALK1;FCSK;PGM2;GALT;HEXB;NPL;GALE;GNPDA2;GNPDA1;GMPPB;CYB5RL;CMAS;HKDC1;GFPT1;GNPNAT1;UGDH;GNE;RENBP;PGM3;UAP1L1;HK2;GMPPA
92,prerank,Thermogenesis,-0.2655526141194051,-1.2989579931557904,0.05499438832772166,0.6075640221566059,1.0,119/191,53.74%,RPS6;PRKACB;NDUFV1;SLC25A29;NDUFS5;ATP5F1D;ND3;KDM1A;COX7C;COX19;HRAS;SMARCC2;SMARCA2;NDUFS3;COX20;NDUFAF8;NDUFS8;COX3;ND2;SMARCA4;CREB3L4;MAPK13;ND6;COX2;ADCY9;UQCRH;CYTB;RPTOR;NDUFB9;ATP6;MLST8;RPS6KB2;FGFR1;SMARCB1;CPT1A;COX11;TSC2;NDUFB11;TSC1;NDUFB8;COX1;ND4;NDUFB7;COX4I1;SLC25A20;LIPE;NDUFB2;COX7A2L;ND1;ATP5MC2;COA5;ATP8;COX6C;ATP5MG;NDUFA10;ATP5MC1;ACSL6;ACTL6A;NDUFS7;MTOR;SMARCE1;UQCRHL;NDUFAF4;NDUFA4;SMARCD1;NDUFA6;ND5;ACTG1;ZNF516;NDUFA3;NDUFB10;SMARCC1;UQCR11;PNPLA2;BMP8B;NDUFA7;BMP8A;NDUFAF2;UQCRB;NDUFC2;ATP5F1A;SMARCD2;RPS6KA3;COX10;COA4;ND4L;PRKAB2;ATP5ME;MGLL;ATP5F1C;NDUFA8;NDUFAB1;ATP5PO;NDUFA11;ATP5PD;KDM3A;UQCRQ;NDUFA13;NDUFV3;NDUFB1;COX14;UQCR10;KRAS;NDUFC1;COA1;NDUFB4;NDUFS6;COX5A;ATP5MC3;NDUFS2;UQCRC1;PRKAA1;CYC1;NDUFC2-KCTD14;CREB3;RPS6KA2;NDUFS4;COX16;MAPK11
93,prerank,Oxidative phosphorylation,-0.28432618835981477,-1.2972478117983979,0.08432304038004751,0.5960474132798356,1.0,74/117,54.74%,ATP6V0E2;NDUFV1;NDUFS5;ATP5F1D;ND3;COX7C;NDUFS3;NDUFS8;COX3;ND2;ND6;COX2;UQCRH;CYTB;NDUFB9;ATP6;COX11;NDUFB11;PPA2;NDUFB8;COX1;ND4;NDUFB7;COX4I1;NDUFB2;COX7A2L;ND1;ATP5MC2;ATP8;COX6C;ATP5MG;NDUFA10;ATP5MC1;ATP6AP1;NDUFS7;UQCRHL;ATP6V0A2;NDUFA4;NDUFA6;ND5;NDUFA3;NDUFB10;UQCR11;NDUFA7;LHPP;UQCRB;NDUFC2;ATP5F1A;COX10;ND4L;ATP5ME;ATP5F1C;NDUFA8;NDUFAB1;ATP5PO;NDUFA11;ATP5PD;UQCRQ;NDUFA13;NDUFV3;NDUFB1;UQCR10;NDUFC1;NDUFB4;NDUFS6;COX5A;ATP5MC3;NDUFS2;UQCRC1;CYC1;NDUFC2-KCTD14;NDUFS4;ATP5PF;ATP6V1H
94,prerank,"Valine, leucine and isoleucine degradation",-0.3552747400079369,-1.2905881029821418,0.1423125794155019,0.6048530097384068,1.0,25/38,45.55%,ABAT;IVD;HADH;BCAT2;OXCT1;ACAD8;HIBADH;ACADS;ACADSB;AACS;MCEE;PCCB;BCKDHA;MCCC1;ACAA2;ALDH3A2;ACAA1;HADHA;HIBCH;MCCC2;HSD17B10;AUH;ACSF3;ALDH6A1;ALDH1B1
95,prerank,Adrenergic signaling in cardiomyocytes,-0.3013587575646165,-1.290454984874173,0.10827250608272507,0.5881054611307925,1.0,26/80,27.28%,TPM2;ATP2B4;PLCB2;ATP2A3;PRKACB;CACNA2D2;PPP2R5D;CAMK2G;ADRB2;ATP1A3;CALM1;ATF4;CACNB1;ATP1A1;CREB3L4;MAPK13;SLC9A1;ADCY9;ATP2B1;PRKCA;AKT3;PPP2R3B;FXYD2;PLCB3;BCL2;CACNA2D3
96,prerank,Adipocytokine signaling pathway,0.2911400253382978,1.2886157664425975,0.13247863247863248,0.19324191090795015,0.989,14/50,11.12%,SOCS3;JAK2;ACSL4;STAT3;TNFRSF1A;NFKBIA;ACSL1;CD36;NFKBIE;TNF;ACSL5;ADIPOR1;CHUK;CPT1B
97,prerank,Viral protein interaction with cytokine and cytokine receptor,0.28505710141417334,1.2775950713087405,0.13658536585365855,0.20074293169211155,0.991,8/53,4.31%,CXCL10;TNFSF10;CCL2;CCR1;TNFRSF1A;LTBR;IL10RB;CSF1
98,prerank,Hypertrophic cardiomyopathy,-0.35729669428151367,-1.2735359171707934,0.15333333333333332,0.6366608944046059,1.0,15/34,35.40%,TPM2;LMNA;ATP2A3;CACNA2D2;ITGB1;ITGB7;EMD;CACNB1;ITGA6;ITGA5;CACNA2D3;CACNA2D4;ITGA3;DAG1;ACTG1
99,prerank,Shigellosis,0.21803916002067764,1.2679070857875063,0.06140350877192982,0.20682923276866544,0.991,42/200,9.58%,TIFA;RBCK1;RIPK2;CASP1;CASP4;CALCOCO2;IL1B;CGAS;UBE2D1;TNFRSF1A;NFKBIA;TLR5;H3-3A;MAPK14;RNF31;MYD88;ILK;TLR4;UBE2D3;SRC;CUL1;TBK1;H3C4;RIPK1;CYTH4;H3-3B;NOD1;ACTN1;PRKCD;GABARAP;H3-5;ACTR3;NLRC4;ARPC5;ARPC3;ELMO2;BCL2L1;ACTR2;TNF;BECN1;HK1;PYCARD
100,prerank,N-Glycan biosynthesis,-0.3402468401025244,-1.2629085689878707,0.15668789808917197,0.6609601275897926,1.0,36/41,59.52%,MGAT4A;MAN1B1;MOGS;B4GALT3;MAN1C1;ST6GAL1;MGAT4B;ALG1;DOLPP1;STT3A;GANAB;DPM3;RPN2;ALG5;ALG12;ALG3;MGAT5;STT3B;DDOST;ALG6;ALG9;RPN1;ALG2;ALG13;FUT8;MAN2A2;MAN1A2;DOLK;MGAT3;SRD5A3;ALG8;MAN2A1;DPM1;DAD1;MGAT2;B4GALT1
101,prerank,RNA polymerase,-0.36478104874836126,-1.2623401824825573,0.16085790884718498,0.6460468768439982,1.0,24/30,55.54%,POLR1E;POLR2H;POLR3GL;POLR2I;POLR1C;POLR3K;POLR3E;POLR2J2;POLR3F;POLR2G;POLR2C;POLR1D;POLR2J3;POLR2D;POLR1B;POLR3H;POLR3B;POLR1H;POLR1A;POLR2K;POLR2L;POLR2F;POLR1F;POLR3C
102,prerank,Salmonella infection,0.218975827548137,1.2574118251548163,0.0625,0.21451203452816792,0.992,37/211,9.08%,CASP5;TNFSF10;MLKL;DYNLT1;RIPK2;CASP1;CASP4;IL1B;CASP7;GSDMD;TNFRSF1A;TLR2;NFKBIA;TLR5;RILP;PAK1;MAPK14;BAK1;MYD88;TCF7L2;TLR4;LY96;PTPRC;RIPK1;CYTH4;RAB5C;TLR6;NOD1;ACTR3;NLRC4;ARPC5;ARPC3;ELMO2;KIF5B;ACTR2;TNF;RAB5A
103,prerank,Circadian rhythm,-0.3917127163250687,-1.2540731751240808,0.19528178243774574,0.6619213435366889,1.0,11/23,35.58%,NR1D1;RORC;BHLHE40;CSNK1E;TPTEP2-CSNK1E;CRY2;RORA;CRY1;RBX1;BTRC;PER1
104,prerank,Cortisol synthesis and secretion,-0.35880563929387216,-1.249899303392253,0.1942257217847769,0.6612384832271385,1.0,9/31,19.97%,PLCB2;PRKACB;ITPR3;ORAI1;CACNA1I;SCARB1;ATF4;CREB3L4;ADCY9
105,prerank,Yersinia infection,0.2304687190457108,1.2487549789947396,0.10119047619047619,0.22049807024262524,0.992,29/119,10.47%,CCL2;FYB1;LCP2;CASP1;IL1B;MEFV;LIMK1;FCGR2A;NFKBIA;MAPK14;MYD88;TLR4;SRC;TBK1;WAS;WIPF1;PTK2B;SKAP2;ACTR3;NLRC4;ARPC5;ARPC3;ELMO2;ACTR2;TNF;PYCARD;TICAM1;PIP5K1A;CHUK
106,prerank,Collecting duct acid secretion,0.36130088123689225,1.2475680697467855,0.2,0.21828207711108347,0.992,5/19,8.07%,ATP6V1B2;ATP6V0D1;ATP6V1G1;CA2;SLC4A1
107,prerank,Diabetic cardiomyopathy,-0.2597356113539216,-1.2450052753984875,0.09688581314878893,0.6643544407159988,1.0,96/164,50.30%,CTSD;MMP9;PLCB2;ATP2A3;NDUFV1;SLC25A6;PARP1;NDUFS5;CAMK2G;ATP5F1D;ND3;COX7C;SLC2A1;PDK2;PRKCZ;PIK3R1;NDUFS3;NDUFS8;COX3;GYS1;ND2;MAPK13;TBC1D4;ND6;COX2;UQCRH;CYTB;NDUFB9;SMAD3;ATP6;PRKCA;NDUFB11;AKT3;NDUFB8;COX1;VDAC3;ND4;NDUFB7;COX4I1;PLCB3;AGER;NDUFB2;COX7A2L;PIK3R2;ND1;ATP5MC2;ATP8;COX6C;NDUFA10;ATP5MC1;PDHA1;NDUFS7;PDHB;MTOR;UQCRHL;NOS3;MAPK9;SLC25A5;NDUFA4;NDUFA6;PDK4;ND5;NDUFA3;NDUFB10;UQCR11;NDUFA7;UQCRB;NDUFC2;ATP5F1A;VDAC1;ND4L;PPP1CA;ATP5F1C;NDUFA8;NDUFAB1;ATP5PO;NDUFA11;ATP5PD;SLC25A4;GFPT1;UQCRQ;NDUFA13;NDUFV3;NDUFB1;GAPDH;UQCR10;NDUFC1;PPARA;VDAC2;NDUFB4;PIK3CD;NDUFS6;AKT1;COX5A;ATP5MC3;MAPK8
108,prerank,Mismatch repair,-0.3942520538227597,-1.244529229390265,0.19160104986876642,0.650297017770321,1.0,18/20,57.86%,LIG1;POLD2;RPA1;POLD1;RFC4;RFC2;PMS2;PCNA;MLH3;POLD4;MSH6;MSH2;RPA3;RFC1;MSH3;MLH1;RPA2;SSBP1
109,prerank,Cysteine and methionine metabolism,-0.3519687833566476,-1.2401201754266704,0.1834862385321101,0.6516895225182758,1.0,18/33,35.10%,LDHB;MRI1;BCAT2;GOT2;SRM;GOT1;GSS;MPST;DNMT1;MTR;SMS;AHCY;KYAT1;ENOPH1;MDH2;MDH1;ADI1;MTAP
110,prerank,Ras signaling pathway,-0.26785452974266377,-1.235054546365418,0.13302217036172695,0.6570261144401411,1.0,41/127,29.65%,RASSF1;ETS1;ZAP70;GNG2;LAT;RASA3;VEGFB;RASGRP2;RASAL3;RALGDS;PLCG1;SYNGAP1;PRKACB;PLA2G4B;RASA4B;JMJD7-PLA2G4B;RASA4;PDGFB;RASGRP1;CSF1R;HRAS;CALM1;RRAS2;PIK3R1;PLA2G6;BAD;ABL1;TIAM1;PRKCA;FLT3LG;RIN1;FGFR1;FASLG;AKT3;EFNA4;PDGFD;RALA;PIK3R2;GNB5;MAPK3;PLAAT3
111,prerank,Pancreatic cancer,0.26546268064676687,1.232249045855401,0.15463917525773196,0.23227781029055883,0.992,7/65,4.87%,STAT1;GADD45B;RALB;STAT3;GADD45G;CDKN1A;BAK1
112,prerank,Endocrine and other factor-regulated calcium reabsorption,-0.3551758813019615,-1.2133554110655018,0.20320855614973263,0.7296038600152448,1.0,11/29,25.20%,ATP2B4;PLCB2;PRKACB;ATP1A3;AP2A2;ATP1A1;ADCY9;ATP2B1;PRKCA;FXYD2;PLCB3
113,prerank,Renin secretion,-0.3552655274274382,-1.208406053602787,0.20588235294117646,0.7342158073106955,1.0,8/29,14.45%,PLCB2;PRKACB;ITPR3;ORAI1;ADRB2;PTGER2;CALM1;PPP3CC
114,prerank,Melanogenesis,-0.3096102413199072,-1.2064544162975965,0.19974059662775617,0.7267024748455494,1.0,17/49,33.73%,TCF7;PLCB2;LEF1;PRKACB;WNT10B;CAMK2G;HRAS;CALM1;DVL1;CREB3L4;ADCY9;PRKCA;PLCB3;MAPK3;WNT10A;MC1R;DVL2
115,prerank,Natural killer cell mediated cytotoxicity,-0.27742194754887683,-1.2046205571294095,0.18004866180048662,0.7189774215749395,1.0,18/92,6.62%,KLRK1;KLRC4-KLRK1;CD247;SH2D1A;LCK;ZAP70;LAT;PRF1;NCR3;SH2D1B;KLRC3;GZMB;PLCG1;NCR1;KLRD1;NFATC2;FYN;CD244
116,prerank,Other glycan degradation,-0.4148665232287319,-1.2028192741926005,0.23866666666666667,0.7112194379339107,1.0,10/15,45.08%,ENGASE;HEXA;FUCA1;MANBA;MAN2C1;HEXB;MAN2B1;NEU3;AGA;MAN2B2
117,prerank,Glucagon signaling pathway,-0.2855258144804064,-1.201798604325466,0.1746987951807229,0.7011065870390516,1.0,29/74,35.97%,LDHB;PLCB2;PRKACB;ITPR3;FBP1;CAMK2G;PHKG1;FOXO1;CALM1;SLC2A1;PPP3CC;ATF4;PHKG2;ACACB;GYS1;PRMT1;CREB3L4;CPT1A;PYGB;AKT3;PLCB3;PFKL;PDHA1;PDHB;PHKA2;SIK2;PDE3B;G6PC3;PFKM
118,prerank,Synaptic vesicle cycle,0.2942858311984502,1.200437670344184,0.1885245901639344,0.2669233457126416,0.994,6/36,6.53%,NAPA;SLC6A12;STX3;ATP6V1B2;ATP6V0D1;ATP6V1G1
119,prerank,RNA transport,-0.25221800903003605,-1.1978054003840695,0.1536723163841808,0.703005102313998,1.0,88/159,50.14%,PABPC4;EIF4B;EEF1A1;NUP210;EIF3F;CYFIP2;EIF3E;POP5;PABPC1;EIF3G;THOC3;UPF3A;EIF4A2;NUP188;PYM1;POM121;AAAS;PNN;EIF3CL;EIF3C;POM121C;RPP21;NUP85;NUP88;EIF2B5;NUP43;EIF2B4;THOC1;XPOT;EIF5B;NXT1;DDX20;ELAC2;EIF4EBP1;EIF3B;GEMIN4;UPF3B;UBE2I;RNPS1;RAN;EIF3H;PHAX;EIF1AX;TARDBP;XPO5;EIF2S3;RPP38;SNUPN;NCBP2;EIF2B1;EIF3A;EIF3I;NUP42;POP7;GEMIN6;RANBP2;EIF3D;NUP133;NUP160;GEMIN5;NDC1;THOC6;GEMIN7;RPP25L;SMN2;DDX19A;RAE1;NUP205;GEMIN8;XPO1;DDX39B;EIF2B2;NUP155;SMN1;RPP30;NUP54;EIF2B3;CLNS1A;SUMO2;DDX19B;POP4;PABPC3;PAIP1;EIF3J;RPP25;NXF1;MAGOH;NCBP1
120,prerank,Olfactory transduction,-0.3700949770887174,-1.1971991969264024,0.23146944083224968,0.6916890526829919,1.0,6/22,15.50%,RGS2;PRKACB;NCALD;CAMK2G;CALM1;ARRB1
121,prerank,Cushing syndrome,-0.2780754550153995,-1.1927923276035455,0.20024570024570024,0.6951500850968824,1.0,20/82,20.03%,TCF7;PLCB2;LEF1;PRKACB;ITPR3;MEN1;WNT10B;ORAI1;CAMK2G;CACNA1I;SCARB1;AXIN2;CDK4;AIP;DVL1;ATF4;CREB3L4;AXIN1;ADCY9;WDR5
122,prerank,Drug metabolism,-0.3103765936237184,-1.1895603399553907,0.23182957393483708,0.6941041523285157,1.0,18/46,21.90%,NME3;GSTM2;IMPDH2;ADH5;CMPK1;GSTM1;RRM1;GUSB;GSTM4;CDA;CYP2D6;GSTP1;MGST3;NME2;NME4;NME1-NME2;DUT;UCKL1
123,prerank,Pancreatic secretion,-0.3211486944379116,-1.184719312449085,0.23177083333333334,0.6991387219888874,1.0,14/41,25.20%,ATP2B4;PLCB2;ATP2A3;ITPR3;PRSS1;ATP1A3;ATP1A1;SLC9A1;ADCY9;ATP2B1;AMY2B;PRKCA;FXYD2;PLCB3
124,prerank,B cell receptor signaling pathway,0.23802437545865607,1.1762624222881506,0.18324607329842932,0.2943300170296675,0.996,13/76,8.06%,DAPP1;PIK3AP1;IFITM1;LYN;LILRB3;LILRB1;NFKBIA;LILRA6;PTPN6;LILRB4;FCGR2B;LILRB2;NFKBIE
125,prerank,Glutathione metabolism,-0.32248190428996104,-1.1720416360435302,0.23728813559322035,0.7328827850212971,1.0,14/36,18.81%,GPX3;GSTM2;ANPEP;GPX7;GPX4;GGT7;GGT1;GSTM1;RRM1;GSTM4;SRM;GSTP1;MGST3;GSS
126,prerank,PPAR signaling pathway,0.2747515500444457,1.17125286478078,0.248868778280543,0.29688984494039616,0.997,6/37,6.30%,GK;ACSL4;PLTP;ACSL1;ILK;CD36
127,prerank,Retrograde endocannabinoid signaling,-0.26664835732781067,-1.1610190798578115,0.24572127139364303,0.7633330490046353,1.0,58/85,53.74%,GNG2;PLCB2;PRKACB;ITPR3;NDUFV1;NDUFS5;ND3;NDUFS3;NDUFS8;ND2;MAPK13;DAGLB;ND6;FAAH;ABHD6;ADCY9;NDUFB9;PRKCA;NDUFB11;NDUFB8;ND4;NDUFB7;PLCB3;NDUFB2;ND1;GNB5;MAPK3;NDUFA10;GNGT2;NDUFS7;MAPK9;NDUFA4;NDUFA6;ND5;NDUFA3;NDUFB10;NDUFA7;NDUFC2;NAPEPLD;ND4L;MGLL;NDUFA8;NDUFAB1;NDUFA11;NDUFA13;NDUFV3;NDUFB1;GNG7;NDUFC1;NDUFB4;NDUFS6;MAPK8;NDUFS2;GNG11;ITPR1;NDUFC2-KCTD14;NDUFS4;MAPK11
128,prerank,RNA degradation,-0.28190042699060003,-1.1598562098018375,0.2438423645320197,0.7548793604884834,1.0,27/68,29.77%,ENO2;PABPC4;LSM2;LSM7;PABPC1;TOB1;EXOSC8;ENO3;DIS3L;EXOSC2;TOB2;EXOSC10;EXOSC7;EXOSC5;PAN2;LSM4;EDC3;DCP1B;EXOSC9;MPHOSPH6;BTG1;EDC4;DDX6;PFKL;CNOT9;EXOSC1;CNOT6
129,prerank,Type II diabetes mellitus,0.31625853191856446,1.1592828822943813,0.2564102564102564,0.3088454682162668,0.998,2/25,1.77%,SOCS1;SOCS3
130,prerank,Thyroid hormone synthesis,-0.3104952091314839,-1.1587423860089114,0.2591623036649215,0.7462026681096067,1.0,13/40,25.20%,GPX3;PLCB2;PRKACB;ITPR3;GPX7;ATP1A3;ATF4;ATP1A1;CREB3L4;ADCY9;PRKCA;FXYD2;PLCB3
131,prerank,Alcoholism,0.22209179917245145,1.156767076063037,0.1977401129943503,0.30803193768639625,0.998,22/103,11.00%,H2BC18;GNB4;GNG10;H4C8;HDAC4;H2BC4;H3-3A;H2AC18;H2AC19;H3C4;CREB5;H3-3B;H2AC20;H3-5;H2AC7;H2BC21;H4C4;GRB2;H2BC12;GNG5;H2BC5;GNB2
132,prerank,cGMP-PKG signaling pathway,-0.26639113213277765,-1.1555648393089828,0.23862238622386223,0.7460084807850277,1.0,24/89,25.20%,ATP2B4;NFATC3;PLCB2;RGS2;IRS2;ATP2A3;ITPR3;NFATC2;SLC25A6;ADRB2;IRAG1;ATP1A3;CALM1;PPP3CC;ATF4;ATP1A1;CREB3L4;BAD;ADCY9;ATP2B1;AKT3;VDAC3;FXYD2;PLCB3
133,prerank,Arginine and proline metabolism,0.30015218621639,1.151658674570552,0.2703862660944206,0.3119646131746159,0.998,3/30,1.75%,LAP3;CNDP2;SAT1
134,prerank,Carbohydrate digestion and absorption,-0.3458235717264273,-1.1502385691973231,0.29934640522875816,0.7536398552494283,1.0,10/25,26.99%,PLCB2;ATP1A3;SLC37A4;PIK3R1;ATP1A1;AMY2B;AKT3;FXYD2;PLCB3;PIK3R2
135,prerank,Pentose phosphate pathway,-0.346904149736347,-1.1475315783643558,0.29362880886426596,0.7524276802166818,1.0,9/23,26.66%,FBP1;PGM1;PRPS1;ALDOC;GPI;TKTL1;PGM2;GLYCTK;PFKL
136,prerank,Biosynthesis of unsaturated fatty acids,-0.3747563537576315,-1.1439651495038239,0.2923898531375167,0.753549782588701,1.0,10/18,36.67%,TECR;ACOT2;HACD3;FADS2;SCP2;HACD2;ACAA1;HSD17B4;HSD17B12;ACOT1
137,prerank,Hippo signaling pathway,-0.26556067542339623,-1.139267339311772,0.2533659730722154,0.7589027429345292,1.0,37/83,42.15%,RASSF1;TCF7;LLGL2;LEF1;PARD6A;ID2;CSNK1E;TPTEP2-CSNK1E;WNT10B;CCND2;AXIN2;PRKCZ;MYC;DVL1;BBC3;AXIN1;SCRIB;SMAD7;LLGL1;SMAD3;DCHS1;NF2;YWHAH;PATJ;BIRC3;WNT10A;DVL2;BTRC;ACTG1;YWHAQ;DLG1;BMP8B;BMP8A;LIMD1;PPP2R1A;PPP1CA;PRKCI
138,prerank,Fructose and mannose metabolism,-0.325605525015655,-1.1389705774747982,0.3072983354673495,0.7482523878891794,1.0,9/29,20.90%,AKR1B1;MPI;FBP1;PMM1;ALDOC;ENOSF1;PMM2;FCSK;KHK
139,prerank,Hematopoietic cell lineage,-0.27127563069954774,-1.1359218202731773,0.25346784363177804,0.7477123879605952,1.0,13/74,5.99%,IL7R;CD2;CD3E;CD3D;CD1C;CD8A;CD5;IL11RA;CD3G;CD7;CD8B;CD4;ANPEP
140,prerank,Aldosterone-regulated sodium reabsorption,-0.37263611761739024,-1.1348305946668673,0.3133514986376022,0.740663796882647,1.0,8/18,29.16%,SGK1;ATP1A3;PIK3R1;ATP1A1;PRKCA;FXYD2;PIK3R2;MAPK3
141,prerank,Glycosaminoglycan biosynthesis,-0.315928454682357,-1.13257422484283,0.2939666238767651,0.7379928460516814,1.0,11/35,26.91%,CHST13;XYLT2;XYLT1;B3GAT3;HS3ST3B1;B4GALT3;CHST14;B3GNT7;HS6ST1;CHPF;CHST2
142,prerank,ECM-receptor interaction,-0.3352306386369891,-1.1308935034122838,0.2936400541271989,0.7335033480085213,1.0,15/27,43.02%,COL6A2;COL9A3;ITGB1;ITGB7;ITGA6;ITGA5;THBS1;CD44;ITGA3;DAG1;COL6A1;SPP1;GP1BB;GP1BA;ITGA2B
143,prerank,Ovarian steroidogenesis,-0.33966993920738675,-1.121285437595684,0.3256445047489824,0.7575003568019131,1.0,7/23,19.97%,PRKACB;PLA2G4B;JMJD7-PLA2G4B;SCARB1;ACOT2;AKR1C3;ADCY9
144,prerank,Thyroid hormone signaling pathway,-0.2568337173929839,-1.1084196094373933,0.29876543209876544,0.7934789698607246,1.0,27/86,26.99%,PLCD1;THRA;PLCB2;PLCG1;ATP2A3;PRKACB;KAT2A;ATP1A3;FOXO1;HRAS;SLC2A1;MYC;PIK3R1;MED24;ATP1A1;BAD;SLC9A1;HDAC1;TBC1D4;PRKCA;TSC2;AKT3;FXYD2;PLCB3;PFKL;HDAC3;PIK3R2
145,prerank,Pathways in cancer,0.1762606576616748,1.1067816355201439,0.23684210526315788,0.37664605180604105,1.0,51/311,9.99%,STAT1;STAT2;PML;FAS;GADD45B;RALB;CSF2RB;JAK2;GNB4;STAT3;IL15RA;GNG10;PIM2;CASP7;IL13RA1;NFKBIA;GADD45G;CDKN1A;NFE2L2;STAT5A;GSTO1;IL15;BAK1;TCF7L2;IFNAR1;IFNAR2;CUL1;PIM1;BID;CSF3R;EGLN1;TFG;PTGS2;NFKB2;IL12RB1;GNA13;TGFB1;HIF1A;XIAP;SPI1;RB1;MAX;BCL2L1;IFNGR2;JAK3;GRB2;NCOA1;RASSF5;FZD2;PTGER4;RASGRP4
146,prerank,MicroRNAs in cancer,-0.2355356793588405,-1.0999477709358474,0.3003533568904594,0.8123876073973758,1.0,50/143,32.52%,CDC25B;MIR25;RASSF1;MMP9;STMN1;IRS2;PLCG1;MIR373;VIM;MIRLET7B;MIRLET7D;MIR324;ATM;PDGFB;MIR106B;CCND2;MIR342;FSCN1;HRAS;ABCB1;EZR;ERBB2;DDIT4;MYC;PIK3R1;CCNG1;MIRLET7A3;HDAC1;HMOX1;ABL1;RPTOR;DNMT1;PRKCA;MIR146A;ITGA5;COMMD3-BMI1;EFNA4;UBE2I;SLC45A3;THBS1;PIK3R2;BCL2;BMI1;MIR331;MAPK3;CD44;MTOR;ST14;FOXP1;MAPK7
147,prerank,PI3K-Akt signaling pathway,-0.22949193360468456,-1.0996307208952614,0.286368843069874,0.8023832325823208,1.0,53/184,27.26%,IL7R;COL6A2;SGK1;GNG2;RPS6;THEM4;EIF4B;VEGFB;IL2RB;COL9A3;PPP2R5D;LPAR5;PDGFB;ITGB1;CCND2;PKN1;CDK4;F2R;CSF1R;RBL2;HRAS;ITGB7;ERBB2;DDIT4;MYC;PIK3R1;ATF4;CD19;GYS1;CREB3L4;BAD;ITGA6;RPTOR;TCL1A;MLST8;EPOR;PRKCA;FLT3LG;RPS6KB2;FGFR1;FASLG;ITGA5;TSC2;AKT3;TSC1;EFNA4;PPP2R3B;EIF4EBP1;PDGFD;THBS1;PIK3R2;BCL2;YWHAH
148,prerank,Ether lipid metabolism,-0.31687507397877807,-1.0984996169759675,0.33643617021276595,0.7952955464178073,1.0,10/28,16.83%,LPCAT4;PLA2G4B;JMJD7-PLA2G4B;LPCAT1;PLD4;PLB1;PAFAH1B3;PAFAH2;PLA2G6;PLD3
149,prerank,Focal adhesion,-0.24472797888430167,-1.0981831784489353,0.3058542413381123,0.7856666740670025,1.0,38/107,37.66%,COL6A2;VEGFB;COL9A3;JUN;FYN;FLNA;FLNB;PDGFB;ITGB1;CCND2;VCL;HRAS;ITGB7;ERBB2;PIK3R1;ARHGAP35;RAPGEF1;BAD;ITGA6;PRKCA;ITGA5;AKT3;PDGFD;THBS1;PIK3R2;BCL2;MAPK3;BIRC3;VAV2;ITGA3;MAPK9;DIAPH1;PIP5K1C;ACTG1;COL6A1;SPP1;PARVB;CAPN2
150,prerank,ABC transporters,0.298878272702544,1.0927365099578485,0.341991341991342,0.3943891727166801,1.0,2/21,0.69%,TAP1;TAP2
151,prerank,Axon guidance,-0.2514130014161454,-1.091233667710435,0.30952380952380953,0.799930183672444,1.0,30/92,30.55%,SEMA4C;NFATC3;EPHB6;PLCG1;PARD6A;ABLIM1;NFATC2;FYN;ITGB1;CAMK2G;PLXNA3;HRAS;PRKCZ;PIK3R1;PPP3CC;PTCH1;SSH1;EPHB4;RYK;EPHA4;ABL1;ROBO3;PRKCA;EFNA4;PIK3R2;EFNB1;MAPK3;NCK2;SSH3;PLXNA1
152,prerank,Apoptosis,0.20256930043497495,1.0883428762552436,0.2608695652173913,0.396727696431918,1.0,23/122,9.38%,TNFSF10;FAS;GADD45B;SEPTIN4;CSF2RB;LMNB1;CASP7;TNFRSF1A;NFKBIA;GADD45G;BAK1;CTSS;CASP10;CFLAR;RIPK1;BID;CTSL;MCL1;XIAP;BCL2L1;CTSZ;TNF;BECN1
153,prerank,GnRH secretion,-0.31040394560627776,-1.0877952333457392,0.35386631716906947,0.8020253085723859,1.0,12/32,29.16%,KCNN4;PLCB2;ITPR3;CACNA1I;HRAS;PIK3R1;ARRB1;PRKCA;AKT3;PLCB3;PIK3R2;MAPK3
154,prerank,Mucin type O-glycan biosynthesis,0.3206897711263288,1.0867476700321907,0.3387096774193548,0.3947495305924991,1.0,6/18,10.36%,B4GALT5;GALNT3;C1GALT1C1;ST6GALNAC2;C1GALT1;GCNT1
155,prerank,Oxytocin signaling pathway,-0.2505984646848699,-1.0815525085252817,0.32,0.8145257779318565,1.0,22/90,21.51%,NFATC3;PLCB2;RGS2;PRKACB;EEF2;ITPR3;JUN;NFATC2;PLA2G4B;CACNA2D2;JMJD7-PLA2G4B;CAMK2G;CAMK1;HRAS;CALM1;PPP3CC;MYL6B;CACNB1;CAMK4;ADCY9;EEF2K;PRKCA
156,prerank,Inflammatory mediator regulation of TRP channels,-0.26981575619213005,-1.0753775323200396,0.3667953667953668,0.8255578003241348,1.0,19/57,26.99%,PLCB2;PRKCQ;PLCG1;PRKCH;PRKACB;ITPR3;PLA2G4B;JMJD7-PLA2G4B;CAMK2G;PTGER2;CALM1;PIK3R1;PLA2G6;MAPK13;ADCY9;PRKCA;PLCB3;TRPV1;PIK3R2
157,prerank,Vascular smooth muscle contraction,-0.26515596909650235,-1.0654032371342974,0.3937888198757764,0.8502696867437781,1.0,18/62,26.37%,PLCB2;PRKCQ;PRKCH;PRKACB;ITPR3;PLA2G4B;JMJD7-PLA2G4B;ADORA2A;IRAG1;CALM1;PLA2G6;MYL6B;ARHGEF1;ADCY9;PRKCA;PPP1R14A;PLCB3;MYH9
158,prerank,Ferroptosis,0.2682882373695076,1.0641668321166389,0.35772357723577236,0.429846506081781,1.0,4/34,4.83%,CYBB;SAT1;ACSL4;ACSL1
159,prerank,Porphyrin and chlorophyll metabolism,-0.33026202860802595,-1.0610747816806987,0.405440414507772,0.8542781753402715,1.0,14/21,49.71%,HMOX2;PPOX;GUSB;ALAD;EPRS1;HMOX1;UROD;UROS;FXN;COX10;HMBS;MMAB;CPOX;EARS2
160,prerank,Long-term potentiation,-0.28580721180707536,-1.0588543877829317,0.41106719367588934,0.8517677146444889,1.0,29/42,61.81%,PLCB2;PRKACB;ITPR3;CAMK2G;HRAS;CALM1;PPP3CC;ATF4;CAMK4;PRKCA;PLCB3;MAPK3;RPS6KA3;PPP1CA;PPP3CB;MAP2K1;KRAS;PPP3CA;ITPR1;ARAF;RPS6KA2;RAP1B;PPP1CB;CALML4;PRKACA;PPP1CC;MAPK1;MAP2K2;CALM3
161,prerank,Lysine degradation,-0.2796055032727718,-1.0555666755614124,0.38866930171277997,0.8527637713788351,1.0,23/44,45.62%,EHMT2;HADH;PLOD1;COLGALT1;SUV39H1;KMT5A;GCDH;EZH1;DLST;KMT2A;SETD1A;PLOD3;NSD2;ALDH3A2;SMYD2;HADHA;KMT5C;NSD3;SETDB2;NSD1;PRDM2;ALDH1B1;DOT1L
162,prerank,Glutamatergic synapse,-0.27093748780564114,-1.0505642650431315,0.39405684754521964,0.859917348819065,1.0,8/48,6.93%,GNG2;PLCB2;PRKACB;ITPR3;HOMER3;SLC38A1;PLA2G4B;JMJD7-PLA2G4B
163,prerank,Inositol phosphate metabolism,-0.2652833004774009,-1.0504417351827673,0.3893805309734513,0.8502212918113541,1.0,15/58,26.25%,PLCD1;PLCB2;PLCG1;ITPKB;PLCH2;INPP5E;ISYNA1;PI4K2A;INPP5B;PIP4K2B;PIK3C2B;IMPA2;PI4KA;PLCB3;INPP4B
164,prerank,Thyroid cancer,0.2605601310383306,1.0401796883682752,0.4194915254237288,0.4701927041319351,1.0,6/30,6.85%,GADD45B;GADD45G;CDKN1A;BAK1;TCF7L2;TFG
165,prerank,Signaling pathways regulating pluripotency of stem cells,-0.25110666425896055,-1.0371081046321917,0.406905055487053,0.8852901800811523,1.0,23/66,30.66%,TCF7;ID3;ID2;WNT10B;AXIN2;TCF3;HRAS;MYC;DVL1;PIK3R1;MAPK13;AXIN1;PCGF1;SMAD3;FGFR1;AKT3;COMMD3-BMI1;OTX1;PIK3R2;REST;BMI1;MAPK3;WNT10A
166,prerank,Pyruvate metabolism,-0.2999013457142085,-1.0346900998296078,0.43953185955786733,0.8835015123479709,1.0,16/28,45.55%,LDHB;ADH5;ACACB;ACYP1;ACSS1;GRHPR;PDHA1;ALDH3A2;GLO1;PDHB;MDH2;MDH1;FH;DLAT;LDHA;ALDH1B1
167,prerank,Amphetamine addiction,-0.28635789082488683,-1.0282728609214133,0.42762284196547146,0.8948559760067653,1.0,10/35,21.51%,PRKACB;JUN;CAMK2G;CALM1;PPP3CC;ATF4;CREB3L4;CAMK4;HDAC1;PRKCA
168,prerank,Ubiquitin mediated proteolysis,0.19700204802454427,1.0266488138339478,0.39849624060150374,0.4901751322593245,1.0,14/124,8.97%,SOCS1;UBE2L6;PML;SOCS3;UBE2D1;UBE2S;UBE2D3;CUL1;HERC3;XIAP;FANCL;UBE2B;COP1;UBE2F
169,prerank,GABAergic synapse,0.2585972714094984,1.0212201442094815,0.4322033898305085,0.49458788860542546,1.0,10/35,11.32%,SLC6A12;GNB4;GNG10;SRC;GLUL;GLS;GABARAP;GNG5;GNB2;SLC38A2
170,prerank,mRNA surveillance pathway,-0.23936728617796016,-1.0150536477089644,0.44727272727272727,0.9295559524020368,1.0,42/82,52.56%,PABPC4;CPSF1;PPP2R5D;PABPC1;UPF3A;PYM1;BCL2L2-PABPN1;PNN;PABPN1;CPSF4;NXT1;DAZAP1;PPP2R3B;UPF3B;GSPT2;RNPS1;SMG6;RNMT;TARDBP;NCBP2;WDR82;CSTF1;MSI2;DDX19A;RNGTT;PPP2R5A;NUDT21;PPP2R1A;PPP1CA;DDX39B;WDR33;CPSF6;DDX19B;PABPC3;NXF1;FIP1L1;MAGOH;NCBP1;CPSF3;PPP2R2D;SMG5;CSTF2
171,prerank,Bladder cancer,-0.28736465885790513,-1.0128057150288192,0.4541935483870968,0.9265225081218688,1.0,8/32,13.82%,RASSF1;DAPK2;MMP9;CXCL8;CDK4;HRAS;ERBB2;MYC
172,prerank,Progesterone-mediated oocyte maturation,-0.24618289531297832,-1.0125834464222392,0.45153374233128835,0.917117782202257,1.0,43/65,59.42%,CDC25B;KIF22;PRKACB;MAD1L1;PIK3R1;ANAPC5;MAPK13;CDC16;ADCY9;CDC23;ANAPC2;AKT3;PIK3R2;MAPK3;MAPK9;PDE3B;ANAPC7;ANAPC1;ANAPC4;RPS6KA3;CDK2;CCNB1;PKMYT1;SPDYE3;ANAPC11;MAP2K1;HSP90AB1;KRAS;PIK3CD;AKT1;MAPK8;PLK1;SPDYE2;ARAF;SPDYE2B;RPS6KA2;MAPK11;STK10;ADCY4;SPDYE6;PRKACA;MAPK1;FZR1
173,prerank,Homologous recombination,-0.29783475234481993,-1.008331414163772,0.46475195822454307,0.9201588530380148,1.0,19/28,51.45%,POLD2;ATM;RPA1;TOP3B;POLD1;MUS81;MRE11;BABAM1;RAD50;XRCC3;RAD51D;ABRAXAS1;TOP3A;RAD52;POLD4;RPA3;TOPBP1;BRCC3;PALB2
174,prerank,Glycerophospholipid metabolism,-0.24531836341313892,-1.0056928296676597,0.4539800995024876,0.9187484647286858,1.0,22/66,23.35%,DGKZ;DGKA;LPCAT4;DGKD;PLA2G4B;JMJD7-PLA2G4B;LPCAT1;PEMT;PLD4;PLB1;GPD1L;GPAT4;DGKQ;PLA2G6;AGPAT4;PLD3;PCYT2;PNPLA7;DGKG;GPCPD1;PLPP5;PTDSS2
175,prerank,Propanoate metabolism,-0.3006161664923657,-1.0044737343492107,0.47963206307490147,0.9125964740075795,1.0,20/27,58.46%,LDHB;ABAT;ACACB;ACADS;MCEE;ACSS1;PCCB;BCKDHA;HADHA;SUCLG2;HIBCH;LDHA;ALDH6A1;SUCLG1;ECHS1;MLYCD;ACAT1;ACACA;DBT;ACOX3
176,prerank,Purine metabolism,-0.23344802443779628,-1.0030165029582092,0.4758961681087763,0.9076003865312328,1.0,45/79,48.75%,AMPD3;AMPD2;NME3;PDE7A;ADA;IMPDH2;AK1;NT5C3B;PGM1;PRPS1;RRM1;ATIC;APRT;NME2;NT5E;HDDC3;NME4;ADCY9;NT5C;NME1-NME2;PGM2;ADK;AK5;GMPS;PFAS;AK3;ITPA;FHIT;ADSL;PDE3B;PDE4A;PDE6G;PDE8A;DCK;PDE6B;PNP;NME1;ADSS2;ADPRM;NTPCR;NUDT2;DGUOK;NME7;PDE1B;PAICS
177,prerank,Huntington disease,-0.2015703981810517,-1.0009203559475852,0.4662983425414365,0.9050529494039029,1.0,144/244,55.57%,GPX3;PLCB2;ERN1;NDUFV1;SLC25A6;GPX7;NDUFS5;ACTR1B;ATP5F1D;POLR2H;ND3;COX7C;SOD1;POLR2I;KLC4;TUBB;NDUFS3;KLC2;NDUFS8;AP2A2;COX3;ND2;CREB3L4;BBC3;HDAC1;ND6;TUBB6;COX2;UQCRH;MAP3K10;CYTB;NDUFB9;PSMD9;ATP6;TAF4;POLR2J2;NDUFB11;NDUFB8;COX1;VDAC3;ND4;NDUFB7;COX4I1;PLCB3;ULK2;ATG14;NDUFB2;COX7A2L;PSMC5;ND1;POLR2G;ATP5MC2;REST;ATP8;COX6C;NDUFA10;ATP5MC1;POLR2C;NDUFS7;HTT;MTOR;UQCRHL;IFT57;MAPK9;SLC25A5;STX1A;DNAH1;NDUFA4;NDUFA6;ND5;SIN3A;POLR2J3;POLR2D;DCTN1;NDUFA3;NDUFB10;NRF1;UQCR11;DNAL4;ULK1;TUBA4A;NDUFA7;UQCRB;NDUFC2;ATP5F1A;AP2M1;VDAC1;BAX;MAP2K7;TBP;TRAF2;ATG2B;ND4L;CLTB;WIPI1;ATP5F1C;NDUFA8;NDUFAB1;TUBB4B;ATP5PO;NDUFA11;CLTCL1;ATP5PD;SLC25A4;AP2B1;UQCRQ;NDUFA13;NDUFV3;NDUFB1;DLG4;UQCR10;PSMC4;NDUFC1;DCTN5;ATG101;VDAC2;KLC1;NDUFB4;PSMD2;NDUFS6;POLR2K;DCTN2;COX5A;TP53;ATP5MC3;MAPK8;NDUFS2;UQCRC1;POLR2L;ITPR1;CYC1;PSMC3;DCTN3;NDUFC2-KCTD14;CREB3;TUBA8;NDUFS4;WIPI2;ATP5PF;PIK3R4;POLR2F;PSMD1;HDAC2;TFAM
178,prerank,Gastric acid secretion,-0.2722657581424455,-0.9920291578820609,0.4915032679738562,0.9240866059030419,1.0,12/37,21.51%,PLCB2;PRKACB;ITPR3;CAMK2G;ATP1A3;CALM1;EZR;HRH2;ATP1A1;SLC9A1;ADCY9;PRKCA
179,prerank,"Glycine, serine and threonine metabolism",-0.32201821575818534,-0.9912264705825945,0.4759427828348505,0.9171031128078521,1.0,7/19,28.50%,AMT;SHMT2;SHMT1;GAMT;GLYCTK;GRHPR;GNMT
180,prerank,Glycolysis / Gluconeogenesis,-0.2603362338601355,-0.9904276844253512,0.49937106918238994,0.9102032468637712,1.0,24/45,46.56%,ENO2;LDHB;FBP1;ADH5;PGM1;ALDOC;GPI;ENO3;PGM2;ACSS1;PFKL;PDHA1;ALDH3A2;GAPDHS;PDHB;G6PC3;PFKM;DLAT;LDHA;ALDH3B1;ENO1;HKDC1;ALDH1B1;GAPDH
181,prerank,Glycosaminoglycan degradation,-0.3376301103780438,-0.9877175191200102,0.49722991689750695,0.9094786759318872,1.0,8/15,33.51%,SGSH;GUSB;IDUA;HGSNAT;HEXA;NAGLU;HEXB;HYAL3
182,prerank,Steroid biosynthesis,-0.3339297871451698,-0.9876633370432542,0.5006821282401092,0.900634838920697,1.0,13/16,63.09%,EBP;LSS;TM7SF2;LBR;DHCR7;HSD17B7;NSDHL;CYP2R1;FDFT1;MSMO1;SOAT1;DHCR24;SC5D
183,prerank,Cell cycle,-0.22658756927593476,-0.9847882815261201,0.5024271844660194,0.9003130342117532,1.0,37/93,36.28%,CDC25B;MCM7;MCM5;MCM6;MCM3;ATM;CCND2;MAD1L1;CDK4;RBL2;MYC;GADD45A;PRKDC;ANAPC5;HDAC1;CDC14A;ABL1;CDC16;CDC23;BUB3;TFDP2;MCM4;ANAPC2;SMAD3;MCM2;CDKN2C;YWHAH;WEE1;DBF4;RBX1;SMC3;SKP2;ANAPC7;PCNA;YWHAQ;ANAPC1;ANAPC4
184,prerank,Ribosome biogenesis in eukaryotes,-0.22541192112789252,-0.9838079298485869,0.49217809867629364,0.8943490244165825,1.0,74/95,65.98%,FBL;NOB1;RMRP;NOP56;POP5;SNU13;REXO2;TCOF1;NAT10;GNL3;CSNK2A2;IMP3;NOP58;DROSHA;BMS1;NXT1;IMP4;RAN;SBDS;NVL;UTP4;RPP38;NHP2;DKC1;LSG1;MDN1;WDR75;EMG1;MPHOSPH10;POP7;EFL1;WDR43;PWP2;GAR1;RNR1;RIOK2;RIOK1;RPP25L;RBM28;RNR2;NOL6;XPO1;FCF1;UTP14A;RPP30;TBL3;POP4;WDR3;GTPBP4;RPP25;NXF1;RRP7A;POP1;NMD3;CSNK2A1;WDR36;CSNK2B;AK6;RNA5-8SN5;RNA5S16;RCL1;GNL2;XRN2;REXO1;RNA5-8SN4;CSNK2A3;RNA5-8SN3;RNA5S5;RNA5-8SN1;RNA5-8SN2;EIF6;RNA5S11;UTP18;HEATR1
185,prerank,Fluid shear stress and atherosclerosis,0.19456799123952556,0.9801667956341108,0.49404761904761907,0.5722542765846931,1.0,12/90,6.89%,ICAM1;CCL2;NCF1;IL1B;TNFRSF1A;NFE2L2;GSTO1;MAPK14;SRC;NCF2;DUSP1;CTSL
186,prerank,Rap1 signaling pathway,-0.21355648726878812,-0.9693505707488843,0.531812725090036,0.9284243773898105,1.0,34/113,26.99%,LAT;SKAP1;VEGFB;RASGRP2;PLCB2;RALGDS;PLCG1;PARD6A;EVL;LPAR5;PDGFB;ITGB1;ADORA2A;RGS14;F2R;CSF1R;HRAS;CALM1;PRKCZ;PIK3R1;RAPGEF1;MAPK13;TIAM1;ADCY9;PRKCA;FGFR1;ARAP3;AKT3;EFNA4;PDGFD;PLCB3;THBS1;RALA;PIK3R2
187,prerank,Hepatocellular carcinoma,-0.21677790038175887,-0.9679899701535905,0.5467455621301776,0.9235753771792669,1.0,41/108,36.59%,TCF7;GSTM2;LEF1;PLCG1;WNT10B;PHF10;GSTM1;AXIN2;CDK4;HRAS;SMARCC2;GSTM4;SMARCA2;MYC;DVL1;PIK3R1;GADD45A;SMARCA4;BAD;GSTP1;AXIN1;MGST3;HMOX1;SMAD3;PRKCA;RPS6KB2;SMARCB1;AKT3;TXNRD2;PIK3R2;DDB2;MAPK3;ACTL6A;WNT10A;MTOR;SMARCE1;DVL2;SMARCD1;ACTG1;SMARCC1;TXNRD1
188,prerank,Starch and sucrose metabolism,-0.3011781639483874,-0.9645915789180163,0.5344603381014305,0.9246130846038525,1.0,6/21,22.76%,PGM1;GPI;GYS1;AMY2B;PGM2;PYGB
189,prerank,Prostate cancer,-0.22915623993127326,-0.960719715995836,0.5346534653465347,0.9275526750035946,1.0,18/72,27.13%,SPINT1;TCF7;MMP9;LEF1;PDGFB;FOXO1;HRAS;ERBB2;PIK3R1;ATF4;CREB3L4;BAD;GSTP1;FGFR1;AKT3;PDGFD;PIK3R2;BCL2
190,prerank,Lysosome,0.17995541279029584,0.9606745791344723,0.5027624309392266,0.6078545606644558,1.0,13/115,7.16%,LAMP3;SORT1;NPC2;CTSA;GNS;GM2A;CTSS;SCARB2;GALC;ATP6V0D1;IGF2R;CTSL;LITAF
191,prerank,Pyrimidine metabolism,0.22072123104889554,0.9532533210212208,0.5449438202247191,0.6150879690408027,1.0,7/43,7.49%,CMPK2;TYMP;DPYD;NT5C2;NT5C3A;UPP1;ENTPD1
192,prerank,One carbon pool by folate,-0.3231077875085211,-0.9526182591948316,0.5490716180371353,0.9424681847222531,1.0,6/15,25.36%,AMT;SHMT2;SHMT1;ATIC;MTR;TYMS
193,prerank,mTOR signaling pathway,-0.210648032478181,-0.9493798802615336,0.5648949320148331,0.9428343599092976,1.0,32/110,31.64%,SGK1;RPS6;EIF4B;NPRL2;PRR5;CASTOR1;WNT10B;HRAS;DDIT4;DVL1;PIK3R1;SLC3A2;WDR59;RPTOR;MLST8;PRKCA;CASTOR2;RPS6KB2;LAMTOR4;TSC2;AKT3;TSC1;EIF4EBP1;ULK2;PIK3R2;STRADA;MAPK3;LPIN1;WNT10A;DEPDC5;STK11;MTOR
194,prerank,Sphingolipid signaling pathway,-0.2166408088404991,-0.9493327354548674,0.5740740740740741,0.9343961023103177,1.0,34/95,41.39%,S1PR5;FCER1A;S1PR1;CTSD;S1PR4;PLCB2;CERS4;FYN;PPP2R5D;DEGS2;HRAS;PRKCZ;PIK3R1;MAPK13;SMPD1;PRKCA;AKT3;SMPD2;PPP2R3B;PLCB3;PIK3R2;BCL2;MAPK3;CERS2;NOS3;MAPK9;PLD2;ABCC1;NSMAF;PPP2R5A;PPP2R1A;BAX;TRADD;TRAF2
195,prerank,Aminoacyl-tRNA biosynthesis,-0.2308327108433875,-0.9426111679002663,0.5825747724317295,0.9446815685432117,1.0,51/66,53.49%,QARS1;TRNC;TRNP;TRNN;TRNY;TRNA;SARS2;TRNS1;VARS2;TRNE;VARS1;TARS2;IARS1;EPRS1;TRNT;HARS1;TRNW;AARS2;LARS1;TRNG;FARSA;TRNS2;TARS3;TRNF;HARS2;TRNH;RARS2;GARS1;GATB;GATC;NARS2;TRNQ;YARS1;PSTK;TRNI;SARS1;DARS1;TRNL2;MARS2;YARS2;PARS2;FARSB;TRNV;EARS2;FARS2;WARS2;AARS1;DARS2;TRND;NARS1;TRNK
196,prerank,GnRH signaling pathway,-0.23145159940547394,-0.9389042090316092,0.5726600985221675,0.9465054424185144,1.0,14/61,21.51%,PLCB2;PRKACB;ITPR3;JUN;PLA2G4B;JMJD7-PLA2G4B;CAMK2G;MAP3K4;HRAS;CALM1;ATF4;MAPK13;ADCY9;PRKCA
197,prerank,Human T-cell leukemia virus 1 infection,0.1631102332725335,0.9318174668138164,0.6451612903225806,0.6510373089373446,1.0,33/174,9.07%,ICAM1;POLB;IL15RA;TNFRSF1A;CD40;LTBR;ZFP36;HLA-DMB;NFKBIA;CDKN1A;RELB;STAT5A;IL15;HLA-G;HLA-C;HLA-E;B2M;HLA-DRA;HLA-DMA;HLA-DQB1;CREB5;HLA-B;NFKB2;TGFB1;HLA-F;XIAP;SPI1;RB1;HLA-A;HLA-DPA1;BCL2L1;JAK3;TNF
198,prerank,Spliceosome,-0.20071879478823412,-0.9301866442343177,0.6314553990610329,0.962664191679966,1.0,103/139,70.14%,SRSF8;LSM2;HNRNPA1;LSM7;HNRNPA1L2;SF3A2;SNRPD2;THOC3;SNRNP70;SNU13;DDX42;PPIE;SNRPA;SNRPD3;SNRPA1;SF3A3;SF3B3;LSM4;PPIH;PRPF31;SNRNP40;RP9;THOC1;SNRPF;PRPF8;PRPF6;PRPF38B;XAB2;SRSF5;SNRNP200;SNRPE;NCBP2;PRPF19;PRPF40B;SRSF6;RBMX;TCERG1;RBM17;DDX46;SNRPC;TXNL4A;WBP11;SRSF2;DDX39B;PHF5A;SRSF7;HNRNPM;HSPA1L;PRPF4;PLRG1;PPIL1;U2SURP;DDX5;EFTUD2;PQBP1;HNRNPA3;U2AF1L4;BCAS2;AQR;PRPF38A;MAGOH;NCBP1;PUF60;DHX16;HNRNPU;SNRPB;LSM5;SRSF10;RBM8A;THOC2;DHX38;CWC15;SRSF3;SF3B5;SRSF1;ACIN1;USP39;SRSF9;CCDC12;PRPF3;PRPF18;SNRPD1;CTNNBL1;ALYREF;SF3B2;U2AF2;MAGOHB;CHERP;RNU1-4;PCBP1;SF3A1;RNU1-3;RNU1-1;SNRPG;ISY1;ZMAT2;TRA2B;LSM8;RNVU1-4;LSM3;BUD31;RBM22;CDC5L
199,prerank,Chemical carcinogenesis,-0.20277536049067657,-0.9281587168082814,0.6152019002375297,0.959779368720182,1.0,32/118,24.31%,SULT1A1;SULT1A2;EPHX1;GSTM2;PRKACB;PAQR7;MIRLET7B;JUN;MIRLET7D;SULT1A3;SULT1A4;EPHX2;ADRB2;GSTM1;HRAS;AIP;GSTM4;MYC;PIK3R1;ARRB1;MIRLET7A3;ATF4;CREB3L4;BAD;GSTP1;MGST3;ADCY9;PRKCA;RPS6KB2;AKT3;EIF4EBP1;IKBKE
200,prerank,Proteoglycans in cancer,-0.20294769480982208,-0.9264097012875407,0.6126760563380281,0.956577299565922,1.0,30/122,23.05%,RPS6;MMP9;EIF4B;TFAP4;PLCG1;PRKACB;ITPR3;FLNA;FLNB;WNT10B;ITGB1;CAMK2G;HRAS;EZR;RRAS2;ERBB2;MYC;PIK3R1;PTCH1;MAPK13;ARHGEF1;SLC9A1;TIAM1;DROSHA;PRKCA;RPS6KB2;FGFR1;FASLG;ITGA5;AKT3
201,prerank,Circadian entrainment,-0.24514769389444124,-0.9199991760731376,0.5971128608923885,0.9656117870509942,1.0,13/41,31.34%,GNG2;PLCB2;PRKACB;ITPR3;CAMK2G;CACNA1I;CALM1;ADCY9;PRKCA;PLCB3;GNB5;MAPK3;GNGT2
202,prerank,VEGF signaling pathway,-0.23949259722357097,-0.9178315697980364,0.5896774193548387,0.9626646218969109,1.0,12/48,23.05%,SH2D2A;PLCG1;NFATC2;PLA2G4B;JMJD7-PLA2G4B;HRAS;PIK3R1;PPP3CC;MAPK13;BAD;PRKCA;AKT3
203,prerank,Tight junction,-0.20779864648389682,-0.9118667696408561,0.6442873969375736,0.9699174837452874,1.0,36/98,43.89%,CD1C;LLGL2;PARD6A;PRKACB;JUN;ARHGEF18;TJP3;ITGB1;CDK4;EZR;ERBB2;PRKCZ;MYL6B;SCRIB;TIAM1;LLGL1;ARPC5L;NF2;MYH9;CLDN9;PATJ;STK11;CLDN15;MAPK9;ACTG1;PCNA;DLG1;RAPGEF6;TUBA4A;WHAMM;PPP2R1A;MAP2K7;PRKAB2;PRKCI;TJAP1;JAM3
204,prerank,Other types of O-glycan biosynthesis,-0.27272577177368384,-0.9073323773710279,0.6215139442231076,0.973306590135999,1.0,10/27,26.55%,POMT1;MFNG;COLGALT1;LFNG;OGT;B4GALT3;ST6GAL1;RFNG;PLOD3;POGLUT1
205,prerank,FoxO signaling pathway,-0.2045674210954796,-0.9032991002830342,0.6488456865127582,0.9751427524809627,1.0,20/96,17.12%,IL7R;SGK1;S1PR1;S1PR4;IRS2;HOMER3;AGAP2;CSNK1E;KLF2;FBXO32;TPTEP2-CSNK1E;ATM;CCND2;FOXO1;RBL2;HRAS;PIK3R1;GADD45A;PRMT1;MAPK13
206,prerank,Longevity regulating pathway,-0.2111197949783387,-0.9005119830336609,0.6414634146341464,0.9739938127075267,1.0,20/79,24.13%,EHMT2;IRS2;PRKACB;SESN1;SOD1;FOXO1;HRAS;PIK3R1;ATF4;CREB3L4;CAMK4;HDAC1;ADCY9;RPTOR;RPS6KB2;TSC2;AKT3;SESN3;TSC1;EIF4EBP1
207,prerank,Platelet activation,-0.20724192139185782,-0.8978502096566204,0.6703296703296703,0.9725573341029683,1.0,17/87,17.35%,RASGRP2;PLCB2;PRKACB;ITPR3;FYN;PLA2G4B;JMJD7-PLA2G4B;ORAI1;ITGB1;RASGRP1;F2R;PRKCZ;P2RX1;PIK3R1;ARHGAP35;MAPK13;ARHGEF1
208,prerank,MAPK signaling pathway,-0.18751646388966553,-0.8975455221160524,0.7018701870187019,0.965244917729021,1.0,34/185,16.25%,CDC25B;DUSP2;MAP4K1;STMN1;NFATC3;VEGFB;RASGRP2;PRKACB;PTPN7;MAP4K2;JUN;PLA2G4B;CACNA2D2;JMJD7-PLA2G4B;FLNA;FLNB;MAPK8IP3;DUSP7;PDGFB;PPP5C;CACNA1I;MAP3K4;RASGRP1;CSF1R;HRAS;RRAS2;ERBB2;MYC;TAB1;PPP3CC;GADD45A;ARRB1;ATF4;CACNB1
209,prerank,Hedgehog signaling pathway,-0.2600658906129693,-0.8957452019128768,0.6454081632653061,0.9617397139507553,1.0,6/31,16.42%,PRKACB;CSNK1E;TPTEP2-CSNK1E;CCND2;ARRB1;PTCH1
210,prerank,Cholinergic synapse,0.19198550822728824,0.8956421944168352,0.6305418719211823,0.7169133547414694,1.0,5/61,2.50%,KCNJ2;JAK2;GNB4;CHRNB2;GNG10
211,prerank,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.26892888740475346,-0.8955414787812274,0.6308100929614874,0.9545658326488022,1.0,14/23,46.39%,PIGL;GPAA1;PIGQ;PIGC;PIGU;PIGX;PIGH;PIGK;MPPE1;PIGP;PIGO;PIGS;PIGY;PIGT
212,prerank,Citrate cycle (TCA cycle),0.23452283394174173,0.8942983070477772,0.6186440677966102,0.7113618030262289,1.0,26/26,76.59%,ACO1;IDH1;SDHD;SDHB;IDH3A;DLD;PCK2;IDH2;SDHC;SDHA;SUCLA2;ACLY;ACO2;CS;OGDH;IDH3G;SUCLG1;DLAT;FH;SUCLG2;MDH1;MDH2;PDHB;PDHA1;IDH3B;DLST
213,prerank,AMPK signaling pathway,-0.20398558198925454,-0.8876882976541887,0.6678700361010831,0.9657109661350054,1.0,24/88,27.36%,IRS2;EEF2;FBP1;PPP2R5D;FOXO1;FASN;PIK3R1;ACACB;GYS1;CREB3L4;HMGCR;RPTOR;EEF2K;RPS6KB2;CPT1A;TSC2;AKT3;TSC1;PPP2R3B;EIF4EBP1;LIPE;PFKL;PIK3R2;STRADA
214,prerank,Epithelial cell signaling in Helicobacter pylori infection,-0.22724003239897025,-0.8873915389666401,0.657465495608532,0.9588363245549616,1.0,6/54,7.79%,CCL5;ATP6V0E2;PLCG1;JUN;CXCL8;CXCL1
215,prerank,"Alanine, aspartate and glutamate metabolism",-0.2920454419329094,-0.8831389720767543,0.6392156862745098,0.9617689971249694,1.0,13/18,48.76%,ABAT;GOT2;CAD;GOT1;ASNS;ALDH5A1;ASL;ADSL;NIT2;ADSS2;GFPT1;GLUD1;ALDH4A1
216,prerank,Protein processing in endoplasmic reticulum,0.15648766978044726,0.8802011909711936,0.8045112781954887,0.7321677427281507,1.0,17/151,6.60%,FBXO6;EIF2AK2;DNAJA1;SEC24D;UBE2D1;PPP1R15A;NFE2L2;EDEM2;BAK1;ATF6;MAN1A1;DNAJC1;UBE2D3;CUL1;MMP24-AS1-EDEM2;UBQLN2;HSPA6
217,prerank,Protein export,-0.2762358901622929,-0.8800626457708125,0.6528150134048257,0.9615382510458998,1.0,12/21,45.74%,SEC11C;OXA1L;SRPRB;SRP68;SRP9;SEC61A1;SEC63;SPCS3;SEC62;SPCS1;SRP72;SEC11A
218,prerank,Gap junction,-0.22429382303058282,-0.8727192828279781,0.6705276705276705,0.9709554801480295,1.0,11/48,25.20%,PLCB2;PRKACB;ITPR3;PDGFB;HRAS;TUBB;TUBB6;ADCY9;PRKCA;PDGFD;PLCB3
219,prerank,Adherens junction,-0.22674996991607732,-0.8704922148445615,0.6727272727272727,0.9685554075300056,1.0,11/48,22.22%,TCF7;LEF1;FYN;NECTIN1;VCL;ERBB2;BAIAP2;CSNK2A2;SMAD3;ACP1;FGFR1
220,prerank,Basal cell carcinoma,-0.2521779190621844,-0.8691155877721999,0.6881443298969072,0.9642895778377429,1.0,8/29,17.73%,TCF7;LEF1;WNT10B;AXIN2;DVL1;GADD45A;PTCH1;AXIN1
221,prerank,Regulation of lipolysis in adipocytes,-0.24853757428752532,-0.8679844988551846,0.651595744680851,0.9597030005914149,1.0,11/29,37.27%,IRS2;PRKACB;ADRB2;PIK3R1;ADCY9;AKT3;LIPE;PIK3R2;PLAAT3;PDE3B;PNPLA2
222,prerank,Leukocyte transendothelial migration,0.17829185496573663,0.8672773560308946,0.7052631578947368,0.7480999472179897,1.0,9/72,7.71%,ICAM1;CYBB;NCF1;MAPK14;VASP;NCF2;PTK2B;ACTN1;NCF4
223,prerank,Non-small cell lung cancer,0.18168050877614747,0.8365057003700409,0.7346938775510204,0.7941064940258272,1.0,11/58,9.50%,GADD45B;STAT3;GADD45G;CDKN1A;STAT5A;BAK1;RB1;KIF5B;JAK3;GRB2;RASSF5
224,prerank,Notch signaling pathway,-0.21695122422188357,-0.8346042863452616,0.7470664928292047,1.0,1.0,11/44,22.29%,DTX3;TLE2;KAT2A;DTX4;MFNG;LFNG;DVL1;HDAC1;RFNG;NCOR2;TLE1
225,prerank,Amyotrophic lateral sclerosis,-0.16313841578324978,-0.8301061791870771,0.8721560130010835,1.0,1.0,139/290,50.20%,GPX3;ERN1;NUP210;ITPR3;NDUFV1;GPX7;UBQLN4;HNRNPA1;HNRNPA1L2;NDUFS5;ACTR1B;ATP5F1D;ND3;COX7C;SOD1;NUP188;ANG;KLC4;SIGMAR1;TUBB;POM121;NDUFS3;KLC2;PPP3CC;CHCHD10;NDUFS8;ATF4;COX3;CCS;ND2;MAPK13;BAD;POM121C;ND6;TUBB6;NUP85;COX2;NUP88;UQCRH;CYTB;NDUFB9;PSMD9;NUP43;XBP1;ATP6;NDUFB11;NXT1;NDUFB8;EIF2AK3;COX1;GABARAPL1;ND4;NDUFB7;COX4I1;ULK2;ATG14;NDUFB2;COX7A2L;PSMC5;BCL2;ND1;ATP5MC2;RAB39B;TARDBP;ATP8;COX6C;NDUFA10;ATP5MC1;ATXN2L;NDUFS7;MTOR;UQCRHL;TOMM40;RANBP2;NUP133;OPTN;NUP160;DNAH1;NDUFA4;NDUFA6;ND5;DCTN1;NDC1;PFN1;ACTG1;NDUFA3;NDUFB10;UQCR11;DNAL4;HDAC6;ULK1;TUBA4A;NDUFA7;UQCRB;NDUFC2;RAE1;ATP5F1A;VDAC1;VCP;NUP205;BAX;TRAF2;ATG2B;ND4L;WIPI1;SRSF7;ATP5F1C;NUP155;DDIT3;NDUFA8;NDUFAB1;ATXN2;TUBB4B;ATP5PO;PPP3CB;NDUFA11;ATP5PD;NUP54;UQCRQ;NDUFA13;NDUFV3;NDUFB1;UQCR10;PSMC4;NDUFC1;DCTN5;ATG101;KLC1;MATR3;HNRNPA3;NDUFB4;PSMD2;NDUFS6;DCTN2;NXF1;COX5A;NCBP1;TP53;ATP5MC3
226,prerank,ErbB signaling pathway,-0.2062909537945632,-0.8246160388121846,0.7753357753357754,1.0,1.0,19/60,33.24%,PLCG1;JUN;CBLB;CAMK2G;HRAS;ERBB2;MYC;PIK3R1;BAD;ABL1;PRKCA;RPS6KB2;AKT3;EIF4EBP1;PIK3R2;MAPK3;NCK2;MTOR;MAPK9
227,prerank,Estrogen signaling pathway,-0.19374285885395584,-0.8225202226986322,0.7732997481108312,1.0,1.0,17/77,27.13%,CTSD;MMP9;PLCB2;PRKACB;ITPR3;JUN;HRAS;CALM1;PIK3R1;ATF4;CREB3L4;ADCY9;KRT18;AKT3;PLCB3;PIK3R2;BCL2
228,prerank,Morphine addiction,0.20811478332962835,0.8181087156897713,0.678714859437751,0.8162943131822096,1.0,4/35,4.17%,PDE4B;GNB4;GNG10;ARRB2
229,prerank,Long-term depression,-0.23062669177118622,-0.8141790315958718,0.7584415584415585,1.0,1.0,5/33,12.57%,PLCB2;ITPR3;PLA2G4B;JMJD7-PLA2G4B;HRAS
230,prerank,Non-alcoholic fatty liver disease,-0.17455414275122805,-0.813926874354527,0.7986111111111112,1.0,1.0,73/131,53.74%,ERN1;IRS2;NDUFV1;JUN;CXCL8;NDUFS5;COX7C;PIK3R1;NDUFS3;MLXIP;NDUFS8;ATF4;COX3;MAPK13;CEBPA;COX2;UQCRH;CYTB;NDUFB9;XBP1;FASLG;NDUFB11;AKT3;NDUFB8;EIF2AK3;COX1;NDUFB7;COX4I1;NDUFB2;COX7A2L;PIK3R2;COX6C;NDUFA10;NDUFS7;UQCRHL;MAPK9;NDUFA4;NDUFA6;IKBKB;NDUFA3;NDUFB10;UQCR11;NDUFA7;UQCRB;NDUFC2;BAX;TRAF2;PRKAB2;SREBF1;DDIT3;NDUFA8;NDUFAB1;NDUFA11;UQCRQ;NDUFA13;NDUFV3;NDUFB1;UQCR10;NDUFC1;PPARA;NDUFB4;PIK3CD;NDUFS6;AKT1;COX5A;MAPK8;NDUFS2;UQCRC1;PRKAA1;CYC1;NDUFC2-KCTD14;NDUFS4;MAPK11
231,prerank,cAMP signaling pathway,-0.18328470780095557,-0.8138192593783711,0.8053855569155447,1.0,1.0,23/100,20.23%,ATP2B4;ATP2A3;PRKACB;JUN;ORAI1;ADORA2A;CAMK2G;ADRB2;ATP1A3;F2R;PTGER2;CALM1;RRAS2;PIK3R1;PTCH1;ATP1A1;CREB3L4;BAD;CAMK4;SLC9A1;TIAM1;ADCY9;ATP2B1
232,prerank,Glycerolipid metabolism,-0.2244337573335878,-0.8132687882693753,0.7523056653491436,1.0,1.0,19/36,39.32%,DGKZ;DGKA;AKR1B1;DGKD;GPAT4;AGK;DGKQ;AGPAT4;DGKG;PLPP5;DGAT1;GLYCTK;DGKE;LPIN1;ALDH3A2;AGPAT1;PNPLA2;TKFC;GPAT2
233,prerank,Serotonergic synapse,-0.21124103881270664,-0.806073484502372,0.7660668380462725,1.0,1.0,6/46,6.93%,GNG2;PLCB2;PRKACB;ITPR3;PLA2G4B;JMJD7-PLA2G4B
234,prerank,Oocyte meiosis,-0.18859836427531637,-0.8059041714259347,0.8200483091787439,1.0,1.0,59/85,64.30%,PRKACB;ITPR3;PPP2R5D;CAMK2G;MAD1L1;CALM1;PPP3CC;ANAPC5;MAPK13;CDC16;ADCY9;CDC23;ANAPC2;YWHAH;MAPK3;RBX1;SMC3;BTRC;ANAPC7;YWHAQ;ANAPC1;ANAPC4;PPP2R5A;RPS6KA3;CDK2;PPP2R1A;CCNB1;PPP1CA;PKMYT1;SPDYE3;PPP3CB;ANAPC11;MAP2K1;STAG3;PTTG1;PLK1;PPP3CA;ITPR1;SPDYE2;SPDYE2B;RPS6KA2;MAPK11;PPP1CB;SMC1A;ADCY4;SPDYE6;CALML4;PRKACA;PPP1CC;MAPK1;SKP1;YWHAZ;PPP2R1B;PPP2R5E;CALM3;SPDYE18;SPDYE1;FBXO5;FBXW11
235,prerank,Fatty acid degradation,-0.2297061851876509,-0.8007752925459158,0.7561929595827901,1.0,1.0,14/31,38.17%,ADH5;HADH;ECI2;GCDH;ECI1;ACADS;ACADSB;CPT1A;ACAA2;ACSL6;ALDH3A2;ACAA1;HADHA;ACADVL
236,prerank,Parkinson disease,-0.16254317264551552,-0.7979002724717527,0.8906077348066298,1.0,1.0,108/206,53.39%,ERN1;RPS27A;PLCG1;PRKACB;ITPR3;NDUFV1;SLC25A6;NDUFS5;ADORA2A;CAMK2G;ATP5F1D;TRAP1;ND3;COX7C;CALM1;UBE2G2;KLC4;TUBB;NDUFS3;KLC2;SEPTIN5;NDUFS8;ATF4;COX3;ND2;ND6;TUBB6;COX2;UQCRH;CYTB;NDUFB9;PSMD9;XBP1;ATP6;NDUFB11;NDUFB8;EIF2AK3;COX1;VDAC3;ND4;NDUFB7;COX4I1;NDUFB2;COX7A2L;PSMC5;ND1;ATP5MC2;ATP8;COX6C;NDUFA10;ATP5MC1;NDUFS7;UBE2G1;UQCRHL;MAPK9;SLC25A5;NDUFA4;NDUFA6;ND5;NDUFA3;NDUFB10;UQCR11;TUBA4A;NDUFA7;UQCRB;NDUFC2;ATP5F1A;TXN2;VDAC1;BAX;GNAL;ND4L;ATP5F1C;DDIT3;NDUFA8;NDUFAB1;TUBB4B;ATP5PO;NDUFA11;ATP5PD;SLC25A4;UQCRQ;NDUFA13;NDUFV3;NDUFB1;UQCR10;PSMC4;NDUFC1;VDAC2;KLC1;NDUFB4;PSMD2;NDUFS6;COX5A;TP53;ATP5MC3;UBA52;MAPK8;PARK7;NDUFS2;UQCRC1;DAXX;ITPR1;CYC1;PSMC3;NDUFC2-KCTD14;TUBA8;NDUFS4
237,prerank,Autophagy,-0.17396825665468763,-0.7961374867513351,0.8409356725146199,1.0,1.0,36/123,32.02%,DAPK2;CTSD;PRKCQ;ERN1;IRS2;PRKACB;ATG4D;TP53INP2;HRAS;RRAS2;HMGB1;DDIT4;PIK3R1;ATG16L1;BAD;RPTOR;MLST8;RPS6KB2;TSC2;AKT3;TSC1;EIF2AK3;GABARAPL1;ATG9B;ATG4B;ULK2;ATG14;EIF2AK4;ATG9A;PIK3R2;BCL2;RAB39B;MAPK3;STK11;MTOR;BNIP3
238,prerank,Amoebiasis,-0.20629505566675876,-0.7904365502258541,0.7766233766233767,1.0,1.0,8/48,14.13%,CD1C;PLCB2;PRKACB;CXCL8;CXCL1;ARG1;VCL;PIK3R1
239,prerank,Cocaine addiction,-0.24330018737619924,-0.7895003206173828,0.7931972789115647,1.0,1.0,13/22,58.23%,PRKACB;JUN;ATF4;CREB3L4;CDK5R1;CDK5;FOSB;GPSM1;DLG4;ATF6B;CREB3;GRIN3B;PRKACA
240,prerank,Regulation of actin cytoskeleton,-0.17127997608764894,-0.7874371701432323,0.857308584686775,1.0,1.0,39/128,35.40%,CYFIP2;LPAR5;PDGFB;ITGB1;F2R;VCL;HRAS;EZR;GIT1;ITGB7;RRAS2;PIK3R1;ARHGAP35;PIP4K2B;BAIAP2;SSH1;ARHGEF1;SLC9A1;ITGA6;TIAM1;FGFR1;ITGA5;ARPC5L;ARHGEF4;PDGFD;BRK1;MYH9;PIK3R2;ARHGEF7;MAPK3;TMSB4X;SSH3;VAV2;ITGA3;DIAPH1;PIP5K1C;RRAS;PFN1;ACTG1
241,prerank,Fanconi anemia pathway,-0.21236435645680796,-0.7863269871933307,0.7669654289372599,0.99585347334769,1.0,20/39,45.51%,FANCE;FANCG;RPA1;FAAP100;TOP3B;MUS81;ERCC1;FANCI;PMS2;CENPX;REV1;FAN1;FANCF;FANCD2;SLX1B;SLX1A;TOP3A;POLH;TELO2;RPA3
242,prerank,Vibrio cholerae infection,-0.2101322249106915,-0.7826409415483554,0.7890625,0.9949409342919269,1.0,12/40,35.40%,ATP6V0E2;PLCG1;PRKACB;ADCY9;PRKCA;KDELR1;ATP6AP1;ATP6V0A2;PDIA4;ERO1A;SEC61A1;ACTG1
243,prerank,Endocytosis,0.13265866866356568,0.7772878584918104,0.9758064516129032,0.8686063332629786,1.0,35/205,10.25%,PML;CHMP5;ARRB2;HLA-G;SMAP2;FOLR2;SRC;HLA-C;HLA-E;IGF2R;WIPF1;CYTH4;RAB31;RAB5C;ARF3;HSPA6;CHMP2B;HLA-B;HLA-F;ACTR3;HLA-A;ARPC5;ARPC3;SPART;KIF5B;ACTR2;RAB5A;CHMP2A;SH3GLB1;CAPZA2;ASAP1;PIP5K1A;SNX6;HSPA8;RAB11FIP4
244,prerank,Breast cancer,-0.18434088770322085,-0.7771470575985147,0.8391089108910891,0.9970447245147035,1.0,21/74,31.64%,TCF7;LEF1;JUN;WNT10B;AXIN2;CDK4;HRAS;ERBB2;MYC;DVL1;PIK3R1;GADD45A;AXIN1;RPS6KB2;FGFR1;AKT3;PIK3R2;DDB2;MAPK3;WNT10A;MTOR
245,prerank,Insulin signaling pathway,-0.17355403268577368,-0.7736273634278464,0.8545673076923077,0.9959079624567896,1.0,27/108,24.13%,RPS6;IRS2;PRKACB;CBLB;FBP1;PPP1R3E;PHKG1;PRKAR1B;FOXO1;HRAS;CALM1;PRKCZ;FASN;PIK3R1;RAPGEF1;PHKG2;ACACB;GYS1;BAD;RPTOR;RPS6KB2;PYGB;TSC2;AKT3;TRIP10;TSC1;EIF4EBP1
246,prerank,Terpenoid backbone biosynthesis,-0.23935572850047943,-0.7664544555840118,0.7850589777195282,1.0,1.0,15/20,68.06%,PCYOX1;MVD;ICMT;HMGCR;RCE1;MVK;DHDDS;PMVK;FNTA;FDPS;ACAT1;ACAT2;PDSS2;NUS1;GGPS1
247,prerank,Chronic myeloid leukemia,0.15888813078554798,0.7559944024338273,0.8697916666666666,0.8883708157649334,1.0,12/67,10.94%,GADD45B;NFKBIA;GADD45G;CDKN1A;STAT5A;BAK1;TGFB1;RB1;BCL2L1;GRB2;CHUK;STAT5B
248,prerank,Endometrial cancer,-0.1904404164604992,-0.7497533921540263,0.863237139272271,1.0,1.0,10/51,17.73%,TCF7;LEF1;AXIN2;HRAS;ERBB2;MYC;PIK3R1;GADD45A;BAD;AXIN1
249,prerank,p53 signaling pathway,-0.18868214499338265,-0.7468413829702465,0.8492462311557789,1.0,1.0,19/54,27.58%,SESN1;ATM;CCND2;CDK4;PIDD1;CCNG1;GADD45A;BBC3;IGFBP3;SIVA1;CD82;TSC2;SESN3;CCNG2;THBS1;EI24;BCL2;TNFRSF10A;DDB2
250,prerank,Galactose metabolism,-0.22987853574677075,-0.7426250939900635,0.8313413014608234,1.0,1.0,9/23,38.51%,AKR1B1;PGM1;GALK1;PGM2;GALT;PFKL;G6PC3;PFKM;GALE
251,prerank,Cellular senescence,-0.16249343709130204,-0.7412361136610391,0.9153936545240893,1.0,1.0,63/124,51.47%,ETS1;NFATC3;ITPR3;NFATC2;SLC25A6;CXCL8;ATM;CCND2;CDK4;FOXO1;RBL2;HRAS;CALM1;RRAS2;MYC;PIK3R1;PPP3CC;GADD45A;MAPK13;IGFBP3;SMAD3;FOXM1;TSC2;AKT3;TSC1;EIF4EBP1;VDAC3;RBBP4;PIK3R2;MAPK3;MTOR;MRE11;MYBL2;TRAF3IP2;RAD9A;SLC25A5;BTRC;RRAS;TRPM7;RAD1;NFATC1;RAD50;CAPN2;VDAC1;CHEK2;CDK2;CCNB1;PPP1CA;RBL1;PPP3CB;E2F2;SLC25A4;MAP2K1;KRAS;VDAC2;PIK3CD;AKT1;E2F1;HIPK2;SIRT1;TP53;HUS1;PPP3CA
252,prerank,Fc epsilon RI signaling pathway,-0.1879791618488314,-0.7407297203150498,0.8441890166028098,1.0,1.0,6/53,6.93%,FCER1A;LAT;PLCG1;FYN;PLA2G4B;JMJD7-PLA2G4B
253,prerank,Glycosphingolipid biosynthesis,-0.22838378140339294,-0.7401013594362202,0.836436170212766,0.9971748939901872,1.0,4/24,18.14%,ST6GALNAC6;FUT7;B4GALT3;HEXA
254,prerank,TGF-beta signaling pathway,-0.19187904647288512,-0.7276661202101783,0.8602015113350125,1.0,1.0,17/46,43.06%,NOG;ID3;ID2;MYC;TGIF1;SMAD7;SMAD3;RPS6KB2;THBS1;MAPK3;MICOS10-NBL1;RBX1;BMP8B;BMP8A;SMURF2;PPP2R1A;RBL1
255,prerank,Alzheimer disease,-0.1427410157444349,-0.7228418086061783,0.9769230769230769,1.0,1.0,146/278,54.20%,APBB1;PLCB2;ERN1;IRS2;ATP2A3;ITPR3;NDUFV1;SLC25A6;CSNK1E;TPTEP2-CSNK1E;WNT10B;NDUFS5;ATP5F1D;AXIN2;ND3;NAE1;COX7C;HRAS;CALM1;KLC4;TUBB;MME;DVL1;PIK3R1;NDUFS3;FADD;KLC2;PPP3CC;NDUFS8;ATF4;COX3;ND2;BAD;AXIN1;CSNK2A2;ND6;TUBB6;COX2;UQCRH;CYTB;NDUFB9;PSMD9;XBP1;ATP6;BACE1;NDUFB11;AKT3;NDUFB8;EIF2AK3;COX1;VDAC3;ND4;NDUFB7;COX4I1;PLCB3;ULK2;ATG14;AGER;NDUFB2;COX7A2L;PSMC5;PIK3R2;ND1;ATP5MC2;CDK5R1;ATP8;COX6C;MAPK3;NDUFA10;ATP5MC1;WNT10A;LRP1;NDUFS7;MTOR;UQCRHL;MAPK9;SLC25A5;DVL2;NDUFA4;NDUFA6;ND5;IKBKB;NDUFA3;NDUFB10;UQCR11;ULK1;TUBA4A;CAPN2;CDK5;NDUFA7;UQCRB;NDUFC2;ATP5F1A;VDAC1;HSD17B10;MAP2K7;TRAF2;ATG2B;ND4L;WIPI1;ATP5F1C;DDIT3;NDUFA8;NDUFAB1;TUBB4B;ATP5PO;PPP3CB;NDUFA11;ATP5PD;SLC25A4;MAP2K1;UQCRQ;NDUFA13;NDUFV3;NDUFB1;GAPDH;UQCR10;APP;PSMC4;KRAS;NDUFC1;ATG101;VDAC2;KLC1;NDUFB4;PIK3CD;PSMD2;NDUFS6;AKT1;COX5A;ATP5MC3;MAPK8;DVL3;NDUFS2;UQCRC1;PPP3CA;ITPR1;CYC1;PSMC3;NDUFC2-KCTD14;ARAF;TUBA8;NDUFS4;FRAT2;CSNK2A1;WIPI2
256,prerank,HIF-1 signaling pathway,-0.16897623269476303,-0.721389302619232,0.896168108776267,1.0,1.0,25/80,33.05%,ENO2;LDHB;RPS6;PLCG1;CAMK2G;ALDOC;SLC2A1;ERBB2;ENO3;PIK3R1;HMOX1;PRKCA;RPS6KB2;AKT3;EIF4EBP1;TIMP1;PFKL;PIK3R2;BCL2;MAPK3;PDHA1;PDHB;MTOR;RBX1;NOS3
257,prerank,Colorectal cancer,-0.169523332964271,-0.7160413435198244,0.9067796610169492,0.9999107086290986,1.0,23/74,33.25%,TCF7;LEF1;RALGDS;JUN;AXIN2;HRAS;MYC;PIK3R1;GADD45A;BBC3;BAD;AXIN1;SMAD3;RPS6KB2;AKT3;RALA;PIK3R2;BCL2;DDB2;MAPK3;MTOR;MAPK9;APPL1
258,prerank,Small cell lung cancer,0.14876773696814805,0.7103255023322864,0.9242424242424242,0.9286522032427129,1.0,10/62,8.90%,GADD45B;NFKBIA;GADD45G;CDKN1A;BAK1;PTGS2;XIAP;RB1;MAX;BCL2L1
259,prerank,Melanoma,0.16383222483906063,0.70118331577625,0.9082969432314411,0.9277441665919751,1.0,4/40,4.87%,GADD45B;GADD45G;CDKN1A;BAK1
260,prerank,Prion disease,-0.14211804769516198,-0.6984017077623631,0.9764044943820225,1.0,1.0,111/214,53.97%,CCL5;PRKACB;ITPR3;NDUFV1;SLC25A6;FYN;NDUFS5;ATP5F1D;ND3;COX7C;SOD1;KLC4;TUBB;PIK3R1;NDUFS3;KLC2;PPP3CC;NDUFS8;ATF4;COX3;ND2;CREB3L4;MAPK13;BAD;CSNK2A2;ND6;TUBB6;COX2;UQCRH;CYTB;NDUFB9;PSMD9;ATP6;NDUFB11;NDUFB8;EIF2AK3;COX1;VDAC3;ND4;NDUFB7;COX4I1;NDUFB2;COX7A2L;PSMC5;PIK3R2;ND1;ATP5MC2;ATP8;COX6C;MAPK3;NDUFA10;ATP5MC1;NDUFS7;UQCRHL;MAPK9;SLC25A5;NDUFA4;NDUFA6;ND5;NDUFA3;NDUFB10;UQCR11;TUBA4A;PRNP;NDUFA7;UQCRB;NDUFC2;ATP5F1A;VDAC1;BAX;ND4L;ATP5F1C;HSPA1L;DDIT3;NDUFA8;NDUFAB1;TUBB4B;ATP5PO;PPP3CB;NDUFA11;ATP5PD;SLC25A4;UQCRQ;NDUFA13;NDUFV3;NDUFB1;UQCR10;PSMC4;NDUFC1;VDAC2;KLC1;NDUFB4;PIK3CD;PSMD2;NDUFS6;COX5A;ATP5MC3;MAPK8;ATF6B;NDUFS2;UQCRC1;PPP3CA;ITPR1;CYC1;PSMC3;NDUFC2-KCTD14;CREB3;TUBA8;NDUFS4;MAPK11;CSNK2A1
261,prerank,Dopaminergic synapse,-0.16532384446698878,-0.6956292826822782,0.9180124223602485,1.0,1.0,17/74,25.20%,GNG2;PLCB2;PRKACB;ITPR3;PPP2R5D;CAMK2G;CALM1;PPP3CC;ARRB1;ATF4;CREB3L4;MAPK13;PRKCA;COMT;AKT3;PPP2R3B;PLCB3
262,prerank,Apelin signaling pathway,-0.16022255582341108,-0.6920034175424065,0.9421383647798742,1.0,1.0,28/86,37.05%,GNG2;RPS6;PLCB2;PRKACB;ITPR3;KLF2;HRAS;CALM1;RRAS2;CAMK4;SLC9A1;ADCY9;SMAD3;RPS6KB2;AKT3;GABARAPL1;PLCB3;LIPE;GNB5;MAPK3;GNGT2;MTOR;NOS3;MEF2B;PDE3B;RRAS;NRF1;SPP1
263,prerank,Peroxisome,-0.17252291262028027,-0.6881465611125199,0.9138576779026217,1.0,1.0,35/61,50.04%,EPHX2;PXMP2;PEX6;ECI2;ECH1;SOD1;ABCD4;PEX5;PHYH;SCP2;PXMP4;PEX11B;PEX16;ACSL6;PEX1;MVK;ACAA1;HSD17B4;PEX10;PEX14;PAOX;SLC25A17;DHRS4;ABCD3;NUDT19;PECR;NUDT7;DECR2;AMACR;HACL1;PEX19;PMVK;PEX2;ACOT8;MPV17
264,prerank,Relaxin signaling pathway,-0.16014898821491455,-0.6867532308644452,0.9334140435835351,0.9982910478573597,1.0,23/78,33.24%,GNG2;MMP9;VEGFB;PLCB2;PRKACB;JUN;HRAS;PRKCZ;PIK3R1;ARRB1;ATF4;CREB3L4;MAPK13;ADCY9;PRKCA;AKT3;PLCB3;PIK3R2;GNB5;MAPK3;GNGT2;NOS3;MAPK9
265,prerank,"Parathyroid hormone synthesis, secretion and action",-0.1655983493419276,-0.6751759268981506,0.9470365699873896,1.0,1.0,18/65,30.56%,PLCB2;GATA3;PRKACB;ITPR3;RUNX2;ARRB1;ATF4;CREB3L4;ARHGEF1;NACA;ADCY9;PRKCA;FGFR1;PLCB3;BCL2;BGLAP;MAPK3;MMP17
266,prerank,Gastric cancer,-0.15828661160709112,-0.6721322700557034,0.946078431372549,0.9981477348545308,1.0,23/75,33.73%,TCF7;LEF1;WNT10B;AXIN2;HRAS;ABCB1;ERBB2;MYC;DVL1;PIK3R1;GADD45A;AXIN1;SMAD3;RPS6KB2;AKT3;PIK3R2;BCL2;DDB2;MAPK3;WNT10A;MTOR;JUP;DVL2
267,prerank,Insulin resistance,-0.15380437409405318,-0.6616282296242143,0.9485924112607099,1.0,1.0,18/80,23.05%,SLC27A1;PRKCQ;IRS2;PPP1R3E;FOXO1;SLC2A1;OGT;PRKCZ;PIK3R1;MLXIP;ACACB;GYS1;CREB3L4;TBC1D4;RPS6KB2;CPT1A;PYGB;AKT3
268,prerank,Pathways of neurodegeneration,-0.12836994649417938,-0.6604337444095933,0.9978494623655914,0.995086288131354,1.0,182/345,55.44%,GPX3;PLCB2;ERN1;RPS27A;PLCG1;ATP2A3;ITPR3;NDUFV1;SLC25A6;CSNK1E;GPX7;TPTEP2-CSNK1E;WNT10B;NDUFS5;ACTR1B;CAMK2G;ATP5F1D;TRAP1;AXIN2;ND3;COX7C;SOD1;HRAS;CALM1;UBE2G2;KLC4;SIGMAR1;TUBB;DVL1;NDUFS3;FADD;KLC2;PPP3CC;SEPTIN5;NDUFS8;ATF4;COX3;CCS;ND2;MAPK13;BAD;AXIN1;CSNK2A2;ND6;TUBB6;COX2;UQCRH;MAP3K10;CYTB;NDUFB9;PSMD9;XBP1;ATP6;PRKCA;FASLG;NDUFB11;NDUFB8;EIF2AK3;COX1;GABARAPL1;VDAC3;ND4;NDUFB7;COX4I1;PLCB3;ULK2;ATG14;AGER;NDUFB2;COX7A2L;PSMC5;BCL2;ND1;ATP5MC2;CDK5R1;RAB39B;TARDBP;ATP8;COX6C;MAPK3;NDUFA10;ATP5MC1;ATXN2L;WNT10A;NDUFS7;UBE2G1;HTT;MTOR;UQCRHL;IFT57;TOMM40;MAPK9;OPTN;SLC25A5;STX1A;DNAH1;DVL2;NDUFA4;NDUFA6;ND5;DCTN1;NDUFA3;NDUFB10;UQCR11;DNAL4;ULK1;TUBA4A;CAPN2;PRNP;CDK5;NDUFA7;UQCRB;NDUFC2;ATP5F1A;VDAC1;VCP;HSD17B10;BAX;MAP2K7;TRAF2;ATG2B;ND4L;WIPI1;ATP5F1C;DDIT3;NDUFA8;NDUFAB1;ATXN2;TUBB4B;ATP5PO;PPP3CB;NDUFA11;ATP5PD;SLC25A4;MAP2K1;UQCRQ;NDUFA13;NDUFV3;NDUFB1;DLG4;UQCR10;APP;PSMC4;KRAS;NDUFC1;DCTN5;ATG101;VDAC2;KLC1;NDUFB4;PSMD2;NDUFS6;DCTN2;COX5A;ATP5MC3;UBA52;MAPK8;PARK7;DVL3;NDUFS2;UQCRC1;PPP3CA;DAXX;ITPR1;CYC1;PSMC3;DCTN3;NDUFC2-KCTD14;ATXN3;ARAF;TUBA8;NDUFS4;MAPK11;FRAT2;CSNK2A1;WIPI2;ATP5PF;ATXN1L;PIK3R4;UBC;PSMD1;CSNK2B
269,prerank,Glioma,-0.16152848732481412,-0.6515911548328177,0.9311639549436797,0.9950739791172727,1.0,15/56,29.16%,PLCG1;PDGFB;CAMK2G;CDK4;CAMK1;HRAS;CALM1;PIK3R1;GADD45A;CAMK4;PRKCA;AKT3;PIK3R2;DDB2;MAPK3
270,prerank,Basal transcription factors,-0.1742633010397396,-0.6328078069256875,0.95125,1.0,1.0,29/37,71.28%,TAF6;GTF2H4;ERCC3;TAF6L;TAF4;ERCC2;TAF9B;TAF11;TAF9;GTF2H3;GTF2I;GTF2F1;TBP;TAF3;TAF5;TAF5L;TAF15;GTF2H1;TAF2;GTF2E2;TAF1;CCNH;CDK7;GTF2E1;GTF2A2;TAF4B;GTF2A1;TBPL1;TAF7
271,prerank,Bacterial invasion of epithelial cells,-0.1589622979954029,-0.6312165426483921,0.9385194479297365,0.9957792351954597,1.0,11/54,26.99%,SEPTIN1;SEPTIN9;ITGB1;VCL;SEPTIN11;PIK3R1;ITGA5;ARPC5L;SEPTIN6;ARHGAP10;PIK3R2
272,prerank,Sphingolipid metabolism,-0.17325691894318473,-0.6173286143848485,0.9341935483870968,0.997209295674905,1.0,6/32,24.22%,CERK;CERS4;DEGS2;SMPD1;SMPD2;SMPD4
273,prerank,Central carbon metabolism in cancer,-0.15679084301389595,-0.6146033953009279,0.9709962168978562,0.9928897405650082,1.0,15/52,31.64%,LDHB;HRAS;SLC2A1;ERBB2;MYC;PIK3R1;SIRT3;FGFR1;AKT3;PFKL;PIK3R2;MAPK3;PDHA1;PDHB;MTOR
274,prerank,Vasopressin-regulated water reabsorption,-0.17087245463975465,-0.5935627472507695,0.9510204081632653,0.9958452115960702,1.0,5/32,19.97%,AQP3;PRKACB;VAMP2;CREB3L4;ADCY9
275,prerank,Nicotinate and nicotinamide metabolism,0.1647261715649706,0.5923686499724851,0.9459459459459459,0.9835777825210746,1.0,4/23,6.18%,NADK;NAMPT;NT5C2;CD38
276,prerank,Neurotrophin signaling pathway,-0.1336700098730302,-0.5873361883786408,0.9904420549581839,0.9926059543103257,1.0,16/95,19.55%,MATK;PLCG1;MAGED1;JUN;SH2B1;CAMK2G;BEX3;HRAS;CALM1;PIK3R1;RAPGEF1;ATF4;MAPK13;BAD;CAMK4;ABL1
277,prerank,beta-Alanine metabolism,0.16359841314924,0.5651803624680399,0.9411764705882353,0.9817872187864121,1.0,2/20,4.57%,CNDP2;DPYD
278,prerank,Renal cell carcinoma,-0.1377321098858828,-0.5497562063572912,0.9937106918238994,0.9971195357462599,1.0,8/57,17.16%,ETS1;JUN;PDGFB;HRAS;SLC2A1;PIK3R1;RAPGEF1;BAD
279,prerank,Mitophagy,-0.12734140673084746,-0.507982227084243,0.9974587039390089,0.998708316082825,1.0,18/62,34.71%,RPS27A;TOMM7;JUN;HRAS;RRAS2;TBC1D17;ATF4;RHOT2;CSNK2A2;EIF2AK3;GABARAPL1;ATG9B;ATG9A;BNIP3;MAPK9;OPTN;PGAM5;RRAS
280,prerank,Spinocerebellar ataxia,-0.10409970236257172,-0.4664529728353845,1.0,0.9972026730013542,1.0,67/106,67.11%,PLCB2;ERN1;ATP2A3;ITPR3;SLC25A6;NOP56;PIK3R1;PSMD9;XBP1;PRKCA;AFG3L2;AKT3;VDAC3;PLCB3;ULK2;ATG14;RORA;PSMC5;PIK3R2;ATXN2L;ATXN10;MTOR;MAPK9;SLC25A5;TWNK;ULK1;VDAC1;TBP;TRAF2;ATG2B;WIPI1;ATXN2;SLC25A4;PSMC4;ATG101;VDAC2;PIK3CD;PSMD2;OPA1;AKT1;MAPK8;ITPR1;PSMC3;ATXN3;WIPI2;ATXN1L;CIC;PIK3R4;PSMD1;PSMD14;GRIN3B;PSMD11;PSMB7;PSMD13;PSMA7;PSMD8;PSMC6;PSMB5;PSMC2;AKT2;PSMD7;PSMC1;PUM2;PUM1;KCNC3;PIK3C3;AMBRA1
